Access the full text.
Sign up today, get DeepDyve free for 14 days.
S. Deuffic-Burban, T. Poynard, M. Sulkowski, J. Wong (2007)
Estimating the future health burden of chronic hepatitis C and human immunodeficiency virus infections in the United StatesJournal of Viral Hepatitis, 14
J. Pawlotsky, I. Lonjon, C. Hézode, B. Raynard, F. Darthuy, J. Rémiré, C. Soussy, D. Dhumeaux (1998)
What strategy should be used for diagnosis of hepatitis C virus infection in clinical laboratories?Hepatology, 27
G. Calleri, G. Cariti, F. Gaiottino, F. Rosa, O. Bargiacchi, S. Audagnotto, S. Quaglia, T. Blasi, P. Romano, A. Traverso, G. Leo, R. Carbone, B. Mastro, M. Tinelli, P. Caramello, G. Perri (2007)
A short course of pegylated interferon-alpha in acute HCV hepatitis.Journal of viral hepatitis, 14 2
A. Lok, B. McMahon (2001)
Chronic hepatitis BHepatology, 45
X. Forns, E. Martínez‐Bauer, A. Feliu, M. García-Retortillo, Marta Martín, Eugénie Gay, M. Navasa, J. Sánchez‐Tapias, M. Bruguera, J. Rodés (2005)
Nosocomial transmission of HCV in the liver unit of a tertiary care centerHepatology, 41
N. Chalasani, C. Manzarbeitia, P. Ferenci, W. Vogel, R. Fontana, M. Voigt, C. Riely, Paul Martin, L. Teperman, J. Jiao, J. López-Talavera (2005)
Peginterferon alfa‐2a for hepatitis C after liver transplantation: Two randomized, controlled trialsHepatology, 41
L. Seeff, K. Lindsay, B. Bacon, T. Kresina, J. Hoofnagle (2001)
Complementary and alternative medicine in chronic liver diseaseHepatology, 34
C. Bennett, S. Silver, B. Djulbegovic, A. Samaras, C. Blau, Kara Gleason, S. Barnato, Kathleen Elverman, D. Courtney, J. McKoy, B. Edwards, C. Tigue, D. Raisch, P. Yarnold, D. Dorr, T. Kuzel, M. Tallman, S. Trifilio, D. West, S. Lai, M. Henke (2008)
Venous thromboembolism and mortality associated with recombinant erythropoietin and darbepoetin administration for the treatment of cancer-associated anemia.JAMA, 299 8
Danni Daniels, Scott Grytdal, A. Wasley (2009)
Surveillance for acute viral hepatitis - United States, 2007.Morbidity and mortality weekly report. Surveillance summaries, 58 3
P. Pradat, H. Tillmann, S. Sauleda, J. Braconier, G. Saracco, M. Thursz, R. Goldin, R. Winkler, A. Alberti, J. Esteban, S. Hadziyannis, M. Rizzetto, H. Thomas, Michael Manns, C. Trépo (2007)
Long‐term follow‐up of the hepatitis C HENCORE cohort: response to therapy and occurrence of liver‐related complicationsJournal of Viral Hepatitis, 14
E. Palomba, P. Manzini, P. Fiammengo, Paola Maderni, G. Saracco, P. Tovo (1996)
Natural history of perinatal hepatitis C virus infection.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 23 1
R. Perez, A. Ferreira, J. Medina-Pestana, V. Lanzoni, Antonio Silva, M. Ferraz (2005)
Is alanine aminotransferase a good marker of histologic hepatic damage in renal transplant patients with hepatitis C virus infection?Clinical Transplantation, 19
O. Nainan, M. Alter, D. Kruszon-Moran, F. Gao, G. Xia, G. Mcquillan, H. Margolis (2006)
Hepatitis C virus genotypes and viral concentrations in participants of a general population survey in the United States.Gastroenterology, 131 2
P. Harrison, J. Lau, R. Williams (1991)
Hepatology.Postgraduate Medical Journal, 67
Xiong Ma (2010)
[The diagnosis and treatment of autoimmune hepatitis].Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology, 18 5
H. Conjeevaram, M. Fried, L. Jeffers, N. Terrault, Thelma Wiley-Lucas, N. Afdhal, Robert Brown, S. Belle, J. Hoofnagle, D. Kleiner, C. Howell (2006)
Peginterferon and ribavirin treatment in African American and Caucasian American patients with hepatitis C genotype 1.Gastroenterology, 131 2
N. Halsey, J. Abramson, P. Chesney, M. Fisher, M. Gerber, D. Gromisch, S. Kohl, S. Marcy, D. Murray, G. Overturf, R. Whitley, R. Yogev (1998)
Hepatitis C Virus InfectionPediatrics, 101
(2001)
Recommendations for preventing transmission of infections among chronic hemodialysis patients.
L. Yeung, T. To, S. King, E. Roberts (2007)
Spontaneous clearance of childhood hepatitis C virus infectionJournal of Viral Hepatitis, 14
Dian-xing Sun, Fu-Guang Zhang, Yun-Qin Geng, De-Sheng Xi (1996)
Hepatitis C transmission by cosmetic tattooing in womenThe Lancet, 347
M. Wagner, M. Huber, T. Berg, H. Hinrichsen, J. Rasenack, T. Heintges, A. Bergk, C. Bernsmeier, D. Häussinger, E. Herrmann, S. Zeuzem (2005)
Peginterferon-alpha-2a (40KD) and ribavirin for 16 or 24 weeks in patients with genotype 2 or 3 chronic hepatitis C.Gastroenterology, 129 2
D. Sylvestre (2002)
Treating hepatitis C in methadone maintenance patients: an interim analysis.Drug and alcohol dependence, 67 2
B. Helbling, W. Jochum, I. Stamenic, M. Knöpfli, A. Cerny, J. Borovička, J. Gonvers, M. Wilhelmi, S. Dinges, B. Müllhaupt, Alicia Esteban, B. Meyer-Wyss, E. Renner, E. Renner (2006)
HCV‐related advanced fibrosis/cirrhosis: randomized controlled trial of pegylated interferon α‐2a and ribavirinJournal of Viral Hepatitis, 13
F. Carrat, F. Bani-Sadr, S. Pol, É. Rosenthal, F. Lunel-Fabiani, A. Benzekri, P. Morand, C. Goujard, G. Pialoux, L. Piroth, D. Salmon-Céron, C. Degott, P. Cacoub, C. Perronne (2004)
Pegylated interferon alfa-2b vs standard interferon alfa-2b, plus ribavirin, for chronic hepatitis C in HIV-infected patients: a randomized controlled trial.JAMA, 292 23
G. Gudmundsson, K. Malinowska, J. Robinson, B. Pisani, J. Méndez, B. Foy, G. Mullen (2003)
Five-year follow-up of hepatitis C-naïve heart transplant recipients who received hepatitis C-positive donor hearts.Transplantation proceedings, 35 4
M. Uchihara, N. Izumi, Y. Sakai, T. Yauchi, S. Miyake, T. Sakai, T. Akiba, F. Marumo, C. Sato (1998)
Interferon Therapy for Chronic Hepatitis C in Hemodialysis Patients: Increased Serum Levels of InterferonNephron, 80
F. Bortolotti, M. Resti, R. Giacchino, C. Crivellaro, L. Zancan, C. Azzari, N. Gussetti, L. Tasso, Stefania Faggion (1998)
Changing epidemiologic pattern of chronic hepatitis C virus infection in Italian children.The Journal of pediatrics, 133 3
P. Renault, J. Hoofnagle, Y. Park, K. Mullen, M. Peters, D. Jones, V. Rustgi, E. Jones (1987)
Psychiatric complications of long-term interferon alfa therapy.Archives of internal medicine, 147 9
M. Gossop, John Marsden, D. Stewart, A. Rolfe (2000)
Patterns of improvement after methadone treatment: 1 year follow-up results from the National Treatment Outcome Research Study.Drug and alcohol dependence, 60 3
A. Tan, J. Brouwer, P. Glue, R. Leusen, R. Kauffmann, S. Schalm, R. Vries, Vroom Bc (2001)
Safety of interferon and ribavirin therapy in haemodialysis patients with chronic hepatitis C: results of a pilot study.Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 16 1
William Lee, J. Dienstag, K. Lindsay, A. Lok, H. Bonkovsky, M. Shiffman, G. Everson, A. Bisceglie, T. Morgan, M. Ghany, C. Morishima, E. Wright, J. Everhart (2004)
Evolution of the HALT-C Trial: pegylated interferon as maintenance therapy for chronic hepatitis C in previous interferon nonresponders.Controlled clinical trials, 25 5
J. Tokars, E. Miller, M. Alter, M. Arduino (2000)
National Surveillance of Dialysis‐Associated Diseases in the United States, 1997Seminars in Dialysis, 13
I. Jacobson, Robert Brown, B. Freilich, N. Afdhal, P. Kwo, J. Santoro, S. Becker, A. Wakil, D. Pound, E. Godofsky, R. Strauss, D. Bernstein, S. Flamm, M. Pauly, P. Mukhopadhyay, L. Griffel, C. Brass (2007)
Peginterferon alfa‐2b and weight‐based or flat‐dose ribavirin in chronic hepatitis C patients: A randomized trialHepatology, 46
Y. Sugawara, M. Makuuchi, Y. Matsui, Y. Kishi, N. Akamatsu, J. Kaneko, N. Kokudo (2004)
Preemptive Therapy for Hepatitis C Virus after Living-Donor Liver TransplantationTransplantation, 78
D. Saha, S. Agarwal (2001)
Hepatitis and HIV infection during haemodialysis.Journal of the Indian Medical Association, 99 4
M. Martinot‐Peignoux, N. Boyer, D. Cazals‐Hatem, B. Pham, A. Gervais, V. Breton, S. Lévy, C. Degott, D. Valla, P. Marcellin (2001)
Prospective study on anti‐hepatitis C virus–positive patients with persistently normal serum alanine transaminase with or without detectable serum hepatitis C virus RNAHepatology, 34
G. Garini, L. Allegri, A. Vaglio, C. Buzio (2005)
Hepatitis C virus-related cryoglobulinemia and glomerulonephritis: pathogenesis and therapeutic strategies.Annali italiani di medicina interna : organo ufficiale della Societa italiana di medicina interna, 20 2
C. Raison, M. Demetrashvili, L. Capuron, Andrew Miller (2005)
Neuropsychiatric Adverse Effects of Interferon-αCNS Drugs, 19
J. Bartlett (2004)
Highly active antiretroviral therapy and sexual risk behavior: A metaanalytic reviewInfectious Diseases in Clinical Practice, 12
M. Prieto, V. Olaso, C. Verdú, J. Córdoba, C. Gisbert, M. Rayón, D. Carrasco, M. Berenguer, M. Higón, J. Berenguer (1995)
Does the healthy hepatitis C virus carrier state really exist? an analysis using polymerase chain reactionHepatology, 22
J. Dumortier, J. Scoazec, P. Chevallier, O. Boillot (2004)
Treatment of recurrent hepatitis C after liver transplantation: a pilot study of peginterferon alfa-2b and ribavirin combination.Journal of hepatology, 40 4
A. Bisceglie, M. Shiffman, G. Everson, K. Lindsay, J. Everhart, E. Wright, William Lee, A. Lok, H. Bonkovsky, T. Morgan, M. Ghany, C. Morishima, K. Snow, J. Dienstag (2008)
Prolonged therapy of advanced chronic hepatitis C with low-dose peginterferon.The New England journal of medicine, 359 23
Y. Benhamou, M. Bochet, V. Martino, F. Charlotte, F. Azria, A. Coutellier, M. Vidaud, F. Bricaire, P. Opolon, C. Katlama, T. Poynard (1999)
Liver fibrosis progression in human immunodeficiency virus and hepatitis C virus coinfected patientsHepatology, 30
D. Dufour, Mageli Talastas, Maria Fernandez, Barbara Harris, D. Strader, L. Seeff (2003)
Low-positive anti-hepatitis C virus enzyme immunoassay results: an important predictor of low likelihood of hepatitis C infection.Clinical chemistry, 49 3
Sanjeev Arora, C. O’Brien, S. Zeuzem, M. Shiffman, M. Diago, A. Tran, P. Pockros, R. Reindollar, E. Gane, K. Patel, N. Wintfeld, Jesse Green (2006)
Treatment of chronic hepatitis C patients with persistently normal alanine aminotransferase levels with the combination of peginterferon α‐2a (40 kDa) plus ribavirin: Impact on health‐related quality of lifeJournal of Gastroenterology and Hepatology, 21
J. Westin, M. Lagging, A. Dhillon, G. Norkrans, A. Romero, J. Pawlotsky, S. Zeuzem, S. Schalm, Elke Verheij-Hart, Francesco Negro, G. Missale, A. Neumann, K. Hellstrand (2007)
Impact of hepatic steatosis on viral kinetics and treatment outcome during antiviral treatment of chronic HCV infectionJournal of Viral Hepatitis, 14
P. Jara, M. Resti, L. Hierro, R. Giacchino, C. Barbera, L. Zancan, C. Crivellaro, E. Sokal, C. Azzari, M. Guido, F. Bortolotti (2003)
Chronic hepatitis C virus infection in childhood: clinical patterns and evolution in 224 white children.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 36 3
P. Marcellin (1999)
Hepatitis C: the clinical spectrum of the disease.Journal of hepatology, 31 Suppl 1
F. Tumminelli, P. Marcellin, S. Rizzo, Salvatore Barbera, Goffredo Corvino, Patrice Furia, Jean-Piette Benhamou, S. Erlinger (1995)
Shaving as potential source of hepatitis C virus infectionThe Lancet, 345
M. Nguyen, H. Trinh, Ruel Garcia, G. Nguyen, Khoa Lam, E. Keeffe (2008)
Higher Rate of Sustained Virologic Response in Chronic Hepatitis C Genotype 6 Treated With 48 Weeks Versus 24 Weeks of Peginterferon Plus RibavirinThe American Journal of Gastroenterology, 103
S. Utsunomiya, K. Yoshioka, T. Wakita, Hachiro Seno, K. Takagi, M. Ishigami, M. Yano, Kazuo Watanabe, Makoto Kobayashi, Kazumasa Watanabe, H. Kishimoto, S. Kakumu (1999)
TT virus infection in hemodialysis patientsAmerican Journal of Gastroenterology, 94
U. Neumann, G. Puhl, M. Bahra, T. Berg, J. Langrehr, R. Neuhaus, P. Neuhaus (2006)
Treatment of Patients with Recurrent Hepatitis C after Liver Transplantation with Peginterferon Alfa-2B Plus RibavirinTransplantation, 82
F. Rosa, O. Bargiacchi, S. Audagnotto, S. Garazzino, G. Cariti, R. Raiteri, G. Perri (2006)
Dose-dependent and genotype-independent sustained virological response of a 12 week pegylated interferon alpha-2b treatment for acute hepatitis C.The Journal of antimicrobial chemotherapy, 57 2
A. Aroldi, P. Lampertico, G. Montagnino, P. Passerini, M. Villa, M. Campise, G. Lunghi, A. Tarantino, B. Cesana, P. Messa, C. Ponticelli (2005)
Natural History of Hepatitis B and C in Renal Allograft RecipientsTransplantation, 79
D. Kaw, D. Malhotra (2006)
HEMATOLOGY: ISSUES IN THE DIALYSIS PATIENT: Platelet Dysfunction and End‐Stage Renal DiseaseSeminars in Dialysis, 19
G. Armstrong, A. Wasley, Edgar Simard, G. Mcquillan, W. Kuhnert, M. Alter (2006)
The Prevalence of Hepatitis C Virus Infection in the United States, 1999 through 2002Annals of Internal Medicine, 144
P. Ferenci, M. Fried, M. Shiffman, Coleman Smith, G. Marinos, F. Gonçales, D. Häussinger, M. Diago, G. Carosi, D. Dhumeaux, A. Craxì, M. Chaneac, K. Reddy (2005)
Predicting sustained virological responses in chronic hepatitis C patients treated with peginterferon alfa-2a (40 KD)/ribavirin.Journal of hepatology, 43 3
C. Thio, Karen Nolt, J. Astemborski, D. Vlahov, K. Nelson, David Thomas (2000)
Screening for Hepatitis C Virus in Human Immunodeficiency Virus-Infected IndividualsJournal of Clinical Microbiology, 38
Nina Singh, T. Gayowski, F. Wannstedt, M. Wagener, J. Fung, I. Marino (1998)
INTERFERON-a FOR PROPHYLAXIS OF RECURRENT VIRAL HEPATITIS C IN LIVER TRANSPLANT RECIPIENTS
M. Jonas (2002)
Children with hepatitis CHepatology, 36
V. Soriano, J. García-Samaniego, R. Bravo, J. González, Á. Castro, J. Castilla, P. Martínez-Odriozola, M. Colmenero, E. Carballo, D. Suárez, F. Rodríguez-Piñero, A. Moreno, J. Romero, J. Pedreira, J. González-Lahoz (1996)
Interferon alpha for the treatment of chronic hepatitis C in patients infected with human immunodeficiency virus. Hepatitis-HIV Spanish Study Group.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 23 3
Christopher Mansell, S. Locarnini (1995)
Epidemiology of Hepatitis C in the EastSeminars in Liver Disease, 15
S. Saab, Denise Kalmaz, N. Gajjar, J. Hiatt, F. Durazo, Steven‐Huy Han, D. Farmer, R. Ghobrial, H. Yersiz, L. Goldstein, C. Lassman, R. Busuttil (2004)
Outcomes of acute rejection after interferon therapy in liver transplant recipientsLiver Transplantation, 10
M. Roland, D. Havlir (2003)
Responding to organ failure in HIV-infected patients.The New England journal of medicine, 348 23
S. Wirth, T. Lang, S. Gehring, P. Gerner (2002)
Recombinant alfa‐interferon plus ribavirin therapy in children and adolescents with chronic hepatitis CHepatology, 36
P. Rossi, T. Bertani, P. Baio, R. Caldara, P. Luliri, F. Tengattini, P. Bellavita, G. Mazzucco, R. Misiani (2003)
Hepatitis C virus-related cryoglobulinemic glomerulonephritis: long-term remission after antiviral therapy.Kidney international, 63 6
G. Foster, G. Tudor-Williams, J. White, L. Regan, M. Newell, L. Pembrey (2003)
Effects of mode of delivery and infant feeding on the risk of mother‐to‐child transmission of hepatitis C virusBJOG: An International Journal of Obstetrics & Gynaecology, 110
E. Kenny‐Walsh (1999)
Clinical outcomes after hepatitis C infection from contaminated anti-D immune globulin. Irish Hepatology Research Group.The New England journal of medicine, 340 16
6. www.who.int/immunization/topics/hepatitis_c/en
M. Angelico, A. Petrolati, R. Lionetti, I. Lenci, P. Burra, M. Donato, M. Merli, M. Strazzabosco, G. Tisone (2007)
A randomized study on Peg-interferon alfa-2a with or without ribavirin in liver transplant recipients with recurrent hepatitis C.Journal of hepatology, 46 6
D. Powell, B. Abramson, J. Balint, S. Belle, J. Bloomer, A. Diehl, J. Frakes, G. Garcia-Tsao, E. Hook, J. Lusher, M. Popovsky, L. Rabeneck, A. Williams, T. Tralka, H. Alter, M. Alter, E. Bray, L. Curtis, J. Everhart, S. Feinstone, J. Ferguson, J. Gress, W. Hall, J. Hoofnagle, Leslye Johnson, T. Kresina, K. Lindsay, A. Lok, P. McCurdy, R. Perrillo, R. Purcell, E. Schiff, W. Schwieterman, L. Seeff, C. Sherman, M. Stolar, A. Trachtenberg (1997)
National Institutes of Health Consensus Development Conference Panel statement: Management of hepatitis CHepatology, 26
J. Campistol, N. Esforzado, Joaquim Martı́nez, L. Roselló, Lluı́s Veciana, J. Modol, J. Casellas, Merçé Pons, Xavier Cuevas, J. Piera, Josep Oliva, J. Costa, J. Barrera, M. Bruguera (1999)
Efficacy and tolerance of interferon-alpha(2b) in the treatment of chronic hepatitis C virus infection in haemodialysis patients. Pre- and post-renal transplantation assessment.Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 14 11
B. Veldt, E. Heathcote, H. Wedemeyer, J. Reichen, W. Hofmann, S. Zeuzem, Michael Manns, B. Hansen, S. Schalm, H. Janssen (2007)
Sustained Virologic Response and Clinical Outcomes in Patients with Chronic Hepatitis C and Advanced FibrosisAnnals of Internal Medicine, 147
M. Biselli, P. Andreone, A. Gramenzi, S. Lorenzini, E. Loggi, F. Bonvicini, C. Cursaro, M. Bernardi (2006)
Pegylated interferon plus ribavirin for recurrent Hepatitis C infection after liver transplantation in naïve and non-responder patients on a stable immunosuppressive regimen.Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver, 38 1
B. Christensson, T. Wiebe, A. Åkesson, A. Widell (2000)
Interferon-α and Ribavirin Treatment of Hepatitis C in Children with Malignancy in RemissionClinical Infectious Diseases, 30
S. Bruno, T. Stroffolini, M. Colombo, S. Bollani, L. Benvegnu', G. Mazzella, A. Ascione, T. Santantonio, F. Piccinino, P. Andreone, A. Mangia, G. Gaeta, M. Persico, S. Fagiuoli, P. Almasio (2007)
Sustained virological response to interferon‐α is associated with improved outcome in HCV‐related cirrhosis: A retrospective studyHepatology, 45
D. Roth, R. Cirocco, K. Zucker, P. Ruiz, A. Viciana, G. Burke, M. Carreño, V. Esquenazi, Joshua Miller (1995)
De novo membranoproliferative glomerulonephritis in hepatitis C virus-infected renal allograft recipients.Transplantation, 59 12
A. Wasley, Jeremy Miller, L. Finelli (2007)
Surveillance for acute viral hepatitis--United States, 2005.Morbidity and mortality weekly report. Surveillance summaries, 56 3
J. Tsai, J. Jeng, M. Ho, W. Chang, Zu-Yau Lin, J. Tsai (1996)
Independent and additive effect modification of hepatitis C and B viruses infection on the development of chronic hepatitis.Journal of hepatology, 24 3
W. Zung (1965)
A SELF-RATING DEPRESSION SCALE.Archives of general psychiatry, 12
M. Opravil, J. Sasadeusz, D. Cooper, J. Rockstroh, N. Clumeck, B. Clotet, J. Montaner, F. Torriani, J. Depamphilis, D. Dieterich (2008)
Effect of Baseline CD4 Cell Count on the Efficacy and Safety of Peginterferon Alfa-2a (40KD) Plus Ribavirin in Patients With HIV/Hepatitis C Virus CoinfectionJAIDS Journal of Acquired Immune Deficiency Syndromes, 47
P. Mohan, C. Colvin, C. Glymph, Roma Chandra, D. Kleiner, K. Patel, N. Luban, H. Alter (2007)
Clinical spectrum and histopathologic features of chronic hepatitis C infection in children.The Journal of pediatrics, 150 2
O. Dalgard, K. Bjøro, K. Hellum, B. Myrvang, S. Ritland, K. Skaug, N. Raknerud, H. Bell (2004)
Treatment with pegylated interferon and ribavarin in HCV infection with genotype 2 or 3 for 14 weeks: A pilot studyHepatology, 40
S. Hsu, Mei‐Hwei Chang, Ding‐Shinn Chen, H. Hsu, Ching Lee (1991)
Non‐A, non‐B hepatitis in children: A clinical, histologic, and serologic studyJournal of Medical Virology, 35
R. Misiani, P. Bellavita, D. Fenili, Omar Vicari, D. Marchesi, P. Sironi, P. Zilio, A. Vernocchi, M. Massazza, G. Vendramin, E. Tanzi, A. Zanetti (1994)
Interferon alfa-2a therapy in cryoglobulinemia associated with hepatitis C virus.The New England journal of medicine, 330 11
P. Marcellin, J. Bernuau, M. Martinot-Peignoux, D. Larzul, Li-Zhe Xu, S. Tran, A. Bezeaud, M. Guimont, M. Levardon, P. Aumont, S. Erlinger, J. Benhamou (1993)
Prevalence of hepatitis C virus infection in asymptomatic anti-HIV1 negative pregnant women and their childrenDigestive Diseases and Sciences, 38
Kaw Kaw, Malhotra Malhotra (2006)
Platelet dysfunction and end?stage renal diseaseSemin Dial, 19
M. Dore, G. Fattovich, A. Sepulveda, G. Realdi (2007)
Cryoglobulinemia Related to Hepatitis C Virus InfectionDigestive Diseases and Sciences, 52
D. Alvarez, D. Dieterich, N. Bräu, L. Moorehead, L. Ball, M. Sulkowski (2006)
Zidovudine use but not weight‐based ribavirin dosing impacts anaemia during HCV treatment in HIV‐infected personsJournal of Viral Hepatitis, 13
G. Fattovich, G. Giustina, S. Favarato, A. Ruol (1996)
A survey of adverse events in 11,241 patients with chronic viral hepatitis treated with alfa interferon.Journal of hepatology, 24 1
John Scott, D. Gretch (2007)
Molecular diagnostics of hepatitis C virus infection: a systematic review.JAMA, 297 7
P. Bedossa, T. Poynard (1996)
An algorithm for the grading of activity in chronic hepatitis CHepatology, 24
M. Shiffman, M. Diago, A. Tran, P. Pockros, R. Reindollar, D. Prati, M. Rodríguez-Torres, P. Lardelli, S. Blotner, S. Zeuzem (2006)
Chronic hepatitis C in patients with persistently normal alanine transaminase levels.Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association, 4 5
D. Roccatello, A. Fornasieri, O. Giachino, D. Rossi, A. Beltrame, G. Banfi, R. Confalonieri, A. Tarantino, S. Pasquali, A. Amoroso, S. Savoldi, V. Colombo, C. Manno, A. Ponzetto, L. Moriconi, A. Pani, R. Rustichelli, G. Belgiojoso, C. Comotti, M. Quarenghi (2007)
Multicenter study on hepatitis C virus-related cryoglobulinemic glomerulonephritis.American journal of kidney diseases : the official journal of the National Kidney Foundation, 49 1
S. Michaels, R. Clark, P. Kissinger (1998)
Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection.The New England journal of medicine, 339 6
J. Pawlotsky, M. Bouvier-Alias, C. Hézode, F. Darthuy, J. Rémiré, D. Dhumeaux (2000)
Standardization of Hepatitis C Virus RNA QuantificationHepatology, 32
H. Patton, K. Patel, C. Behling, D. Bylund, L. Blatt, M. Vallée, Shanon Heaton, A. Conrad, P. Pockros, J. McHutchison (2004)
The impact of steatosis on disease progression and early and sustained treatment response in chronic hepatitis C patients.Journal of hepatology, 40 3
L. Hourigan, G. Macdonald, D. Purdie, Vicki Whitehall, Claudia Shorthouse, A. Clouston, E. Powell (1999)
Fibrosis in chronic hepatitis C correlates significantly with body mass index and steatosisHepatology, 29
H. Rosen, Paul Martin (1998)
Hepatitis C infection in patients undergoing liver retransplantation.Transplantation, 66 12
J. Airoldi, V. Berghella (2006)
Hepatitis C and PregnancyObstetrical & Gynecological Survey, 61
C. Toth, M. Pascual, R. Chung, F. Graeme-Cook, J. Dienstag, A. Bhan, A. Cosimi (1998)
Hepatitis C virus-associated fibrosing cholestatic hepatitis after renal transplantation: response to interferon-alpha therapy.Transplantation, 66 9
M. Tong, N. El-Farra, Andrew Reikes, R. Co (1995)
Clinical outcomes after transfusion-associated hepatitis C.The New England journal of medicine, 332 22
L. Radloff (1977)
The CES-D ScaleApplied Psychological Measurement, 1
J. Wong, R. Koff (2000)
Watchful Waiting with Periodic Liver Biopsy versus Immediate Empirical Therapy for Histologically Mild Chronic Hepatitis C: A Cost-Effectiveness AnalysisAnnals of Internal Medicine, 133
C. Mazzaro, F. Zorat, M. Caizzi, C. Donada, G. Gennaro, L. Maso, G. Carniello, L. Virgolini, U. Tirelli, G. Pozzato (2005)
Treatment with peg-interferon alfa-2b and ribavirin of hepatitis C virus-associated mixed cryoglobulinemia: a pilot study.Journal of hepatology, 42 5
H. Zylberberg, Y. Benhamou, J. Lagneaux, A. Landau, M. Chaix, H. Fontaine, M. Bochet, T. Poynard, C. Katlama, G. Pialoux, C. Bréchot, S. Pol (2000)
Safety and efficacy of interferon-ribavirin combination therapy in HCV-HIV coinfected subjects: an early reportGut, 47
E. Heathcote, M. Shiffman, W. Cooksley, G. Dusheiko, Samuel Lee, Luis Balart, R. Reindollar, R. Reddy, T. Wright, A. Lin, J. Hoffman, J. Pamphilis (2000)
Peginterferon alfa-2a in patients with chronic hepatitis C and cirrhosis.The New England journal of medicine, 343 23
F. Lunel, C. Robert, P. Munier, J. Cadranel, C. Fretz, M. Perrin, L. Frangeul, P. Grippon, B. Bernard, P. Opolon (1995)
Hepatitis virus infections in heart transplant recipients.Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 49 3
H. Sahi, N. Zein, A. Mehta, H. Blazey, Kathryn Meyer, M. Budev (2007)
Outcomes after lung transplantation in patients with chronic hepatitis C virus infection.The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation, 26 5
N. Kamar, Lionel Rostaing, Laurent Alric (2006)
Treatment of hepatitis C-virus-related glomerulonephritis.Kidney international, 69 3
Gastroenterology, 108
J. Carrión, M. Navasa, M. García-Retortillo, J. García‐Pagán, G. Crespo, M. Bruguera, J. Bosch, X. Forns (2007)
Efficacy of antiviral therapy on hepatitis C recurrence after liver transplantation: a randomized controlled study.Gastroenterology, 132 5
B. Pereira, S. Natov, B. Bouthot, B. Murthy, R. Ruthazer, C. Schmid, A. Levey (1998)
Effect of hepatitis C infection and renal transplantation on survival in end-stage renal disease1Kidney International, 53
J. Donahue, A. Muñoz, P. Ness, Donald Brown, D. Yawn, Hugh McAllister, B. Reitz, K. Nelson (1992)
The declining risk of post-transfusion hepatitis C virus infection.The New England journal of medicine, 327 6
S. Tang, I. Cheng, V. Leung, Un Kuok, A. Tang, Yiu Ho, K. Lai, Tak Chan (2003)
Successful treatment of hepatitis C after kidney transplantation with combined interferon alpha-2b and ribavirin.Journal of hepatology, 39 5
I. Jacobson, F. Ahmed, M. Russo, E. Lebovics, D. Dieterich, S. Esposito, N. Bach, F. Klion, H. Tobias, L. Antignano, Robert Brown, David Gabbaizadeh, J. Geders, H. Levendoglu (2004)
Interferon alfa-2b [correction of alpha-2b]and ribavirin for patients with chronic hepatitis C and normal ALT.The American journal of gastroenterology, 99 9
Y. Jeong, B. Kim (2003)
Peginterferon Alfa-2a Plus Ribavirin for Chronic Hepatitis C Virus Infection
E. Powell, J. Jonsson, A. Clouston (2005)
Steatosis: Co‐factor in other liver diseasesHepatology, 42
I. Rowe, K. Webb, B. Gunson, N. Mehta, S. Haque, J. Neuberger (2008)
The impact of disease recurrence on graft survival following liver transplantation: a single centre experienceTransplant International, 21
D. Samuel, X. Forns, M. Berenguer, C. Trautwein, A. Burroughs, M. Rizzetto, C. Trépo (2006)
Report of the monothematic EASL conference on liver transplantation for viral hepatitis (Paris, France, January 12-14, 2006).Journal of hepatology, 45 1
K. Ishak, A. Baptista, L. Bianchi, F. Callea, J. Groote, F. Gudat, H. Denk, V. Desmet, G. Korb, R. Macsween (1995)
Histological grading and staging of chronic hepatitis.Journal of Hepatology, 22
D. Mousa, A. Abdalla, Ghada Al-Shoail, M. Al-Sulaiman, F. al-Hawas, A. Al-Khader (2004)
Alpha-interferon with ribavirin in the treatment of hemodialysis patients with hepatitis C.Transplantation proceedings, 36 6
V. Mazzaferro, A. Tagger, M. Schiavo, E. Regalia, A. Pulvirenti, M. Ribero, J. Coppa, R. Romito, L. Burgoa, N. Zucchini, T. Urbánek, F. Bonino (2001)
Prevention of recurrent hepatitis C after liver transplantation with early interferon and ribavirin treatment.Transplantation proceedings, 33 1-2
A. Landau, D. Batisse, C. Piketty, R. Jian, M. Kazatchkine (2000)
Lack of interference between ribavirin and nucleosidic analogues in HIV/HCV co-infected individuals undergoing concomitant antiretroviral and anti-HCV combination therapy.AIDS, 14 12
A. Muir, J. Bornstein, P. Killenberg (2004)
Peginterferon alfa-2b and ribavirin for the treatment of chronic hepatitis C in blacks and non-Hispanic whites.The New England journal of medicine, 350 22
M. Sulkowski, D. Thomas, R. Chaisson, R. Moore (2000)
Hepatotoxicity associated with antiretroviral therapy in adults infected with human immunodeficiency virus and the role of hepatitis C or B virus infection.JAMA, 283 1
M. Marcellini, L. Kondili, D. Comparcola, E. Spada, M. Sartorelli, Massimo Palumbo, M. Rapicetta (1997)
High dosage alpha-interferon for treatment of children and young adults with chronic hepatitis C disease.The Pediatric infectious disease journal, 16 11
R. Bloom, V. Rao, F. Weng, R. Grossman, D. Cohen, K. Mange (2002)
Association of hepatitis C with posttransplant diabetes in renal transplant patients on tacrolimus.Journal of the American Society of Nephrology : JASN, 13 5
W. Geber, S. Lefkowitz, C. Hung (1975)
Effect of morphine, hydromorphone, methadone, mescaline, trypan blue, vitamin A, sodium salicylate, and caffeine on the serum interferon level in response to viral infection.Archives internationales de pharmacodynamie et de therapie, 214 2
H. Lane, V. Davey, J. Kovacs, J. Feinberg, J. Metcalf, B. Herpin, R. Walker, L. Deyton, R. Davey, J. Falloon, M. Polis, N. Salzman, M. Baseler, H. Masur, A. Fauci (1990)
Interferon-α in patients with asymptomatic human immunodeficiency virus (HIV) infection.Annals of Internal Medicine, 112
R. Weber, C. Sabin, N. Friis‐Møller, P. Reiss, W. El-Sadr, O. Kirk, F. Dabis, M. Law, C. Pradier, S. Wit, B. Åkerlund, G. Calvo, A. Monforte, M. Rickenbach, B. Ledergerber, A. Phillips, J. Lundgren (2006)
Liver-related deaths in persons infected with the human immunodeficiency virus: the D:A:D study.Archives of internal medicine, 166 15
N. Kamar, C. Mariat, M. Delahousse, J. Dantal, A. Najjar, É. Cassuto, N. Lefrançois, O. Cointault, G. Touchard, F. Villemain, F. Giambattista, P. Benhamou (2007)
Diabetes mellitus after kidney transplantation: a French multicentre observational study.Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 22 7
Czaja Czaja, Freese Freese (2002)
Diagnosis and treatment of autoimmune hepatitisHEPATOLOGY, 36
A. Sabry, M. Sobh, W. Irving, A. Grabowska, B. Wagner, S. Fox, G. Kudesia, A. Meguid, El Nahas (2002)
A comprehensive study of the association between hepatitis C virus and glomerulopathy.Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 17 2
A. Mele, R. Corona, M. Tosti, F. Palumbo, A. Moiraghi, F. Novaco, C. Galanti, R. Bernacchia, P. Ferraro (1995)
Beauty treatments and risk of parenterally transmitted hepatitis: results from the hepatitis surveillance system in Italy.Scandinavian journal of infectious diseases, 27 5
R. Fontana, J. Israel, Paula LeClair, B. Banner, K. Tortorelli, N. Grace, R. Levine, Gale Fiarman, M. Thiim, A. Tavill, H. Bonkovsky (2000)
Iron reduction before and during interferon therapy of chronic hepatitis C: Results of a multicenter, randomized, controlled trialHepatology, 31
HEPATOLOGY, 36
C. Raison, Andrew Miller (2001)
The neuroimmunology of stress and depression.Seminars in clinical neuropsychiatry, 6 4
F. Fabrizi, Paul Martin, V. Dixit, S. Bunnapradist, F. Kanwal, G. Dulai (2005)
Post‐Transplant Diabetes Mellitus and HCV Seropositive Status After Renal Transplantation: Meta‐Analysis of Clinical StudiesAmerican Journal of Transplantation, 5
T. Bizollon, Si Ahmed, S. Radenne, M. Chevallier, P. Chevallier, P. Parvaz, S. Guichard, C. Ducerf, J. Baulieux, F. Zoulim, C. Trépo (2003)
Long term histological improvement and clearance of intrahepatic hepatitis C virus RNA following sustained response to interferon-ribavirin combination therapy in liver transplanted patients with hepatitis C virus recurrenceGut, 52
L. Pembrey, M. Newell, P. Tovo (2005)
The management of HCV infected pregnant women and their children European paediatric HCV network.Journal of hepatology, 43 3
L. Seeff, T. Curto, G. Szabo, G. Everson, H. Bonkovsky, J. Dienstag, M. Shiffman, K. Lindsay, A. Lok, A. Bisceglie, William Lee, M. Ghany (2007)
Herbal product use by persons enrolled in the hepatitis C Antiviral Long‐Term Treatment Against Cirrhosis (HALT‐C) TrialHepatology, 47
M. Shiffman, J. Salvatore, Sarah Hubbard, A. Price, R. Sterling, R. Stravitz, V. Luketic, A. Sanyal (2007)
Treatment of chronic hepatitis C virus genotype 1 with peginterferon, ribavirin, and epoetin alphaHepatology, 46
A. Weigert, A. Schafer (1998)
Uremic bleeding: pathogenesis and therapy.The American journal of the medical sciences, 316 2
L. Lemos, R. Perez, M. Lemos, V. Lanzoni, S. Draibe, I. Silva, Antonio Silva, M. Ferraz (2007)
Hepatitis C in Chronic Kidney Disease: Predialysis Patients Present More Severe Histological Liver Injury than Hemodialysis Patients?American Journal of Nephrology, 27
E. Otón, R. Bárcena, S. García-Garzón, A. Moreno-Zamora, A. Moreno, M. García‐González, C. Blesa, J. Foruny, P. Ruiz (2005)
Pegylated interferon and ribavirin for the recurrence of chronic hepatitis C genotype 1 in transplant patients.Transplantation proceedings, 37 9
Wen-Chin Lee, K. Shu, Chi-hung Cheng, Ming-Ju Wu, Cheng-Hsu Chen, J. Lian (2001)
Long-Term Impact of Hepatitis B, C Virus Infection on Renal TransplantationAmerican Journal of Nephrology, 21
R. Fissell, J. Bragg-Gresham, J. Woods, M. Jadoul, B. Gillespie, S. Hedderwick, H. Rayner, R. Greenwood, T. Akiba, E. Young (2003)
Patterns of hepatitis C prevalence and seroconversion in hemodialysis units from three continents: the DOPPS.Kidney international, 65 6
J. Goedert, Bingshu Chen, L. Preiss, L. Aledort, P. Rosenberg (2007)
Original Contribution Reconstruction of the Hepatitis C Virus Epidemic in the US Hemophilia Population, 1940–1990
R. Moreira, M. Lemos, C. Longui, C. Granato (2005)
Hepatitis C and hemodialysis: a review.The Brazilian journal of infectious diseases : an official publication of the Brazilian Society of Infectious Diseases, 9 4
G. Matthews, I. Kronborg, G. Dore (2005)
Treatment for hepatitis C virus infection among current injection drug users in Australia.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 40 Suppl 5
M. Romero‐Gomez, María Viloria, R. Andrade, J. Salmerón, M. Diago, C. Fernández-Rodríguez, R. Corpas, Marina Cruz, L. Grande, Luis Vázquez, Paloma Muñoz-de-Rueda, P. López-Serrano, A. Gila, María Gutiérrez, C. Pérez, Á. Ruíz‐Extremera, E. Suárez, Jesús Castillo (2005)
Insulin resistance impairs sustained response rate to peginterferon plus ribavirin in chronic hepatitis C patients.Gastroenterology, 128 3
R. Cheruvattath, Marianne Rosati, M. Gautam, H. Vargas, J. Rakela, V. Balan (2007)
Pegylated Interferon and Ribavirin Failures: Is Retreatment an Option?Digestive Diseases and Sciences, 52
J. Dienstag (2002)
The role of liver biopsy in chronic hepatitis CHepatology, 36
E. Mast, L. Hwang, Dexter Seto, F. Nolte, O. Nainan, Heather Wurtzel, M. Alter (2005)
Risk factors for perinatal transmission of hepatitis C virus (HCV) and the natural history of HCV infection acquired in infancy.The Journal of infectious diseases, 192 11
Vogt Vogt, Lang Lang, Frosner Frosner, Klingler Klingler, Sendl Sendl, Zeller Zeller (1999)
Prevalence and clinical outcome of hepatitis C infection in children who underwent cardiac surgery before the implementation of blood?donor screeningN Engl J Med, 341
J. McHutchison, G. Dusheiko, M. Shiffman, M. Rodríguez-Torres, S. Sigal, M. Bourliere, T. Berg, S. Gordon, F. Campbell, D. Theodore, N. Blackman, J. Jenkins, N. Afdhal (2007)
Eltrombopag for thrombocytopenia in patients with cirrhosis associated with hepatitis C.The New England journal of medicine, 357 22
D. Samuel, T. Bizollon, C. Féray, B. Roche, Si Ahmed, C. Lemonnier, M. Cohard, M. Reynés, M. Chevallier, C. Ducerf, J. Baulieux, M. Geffner, J. Albrecht, H. Bismuth, C. Trépo (2003)
Interferon-alpha 2b plus ribavirin in patients with chronic hepatitis C after liver transplantation: a randomized study.Gastroenterology, 124 3
G. Davis, J. Wong, J. McHutchison, M. Manns, J. Harvey, J. Albrecht (2003)
Early virologic response to treatment with peginterferon alfa‐2b plus ribavirin in patients with chronic hepatitis CHepatology, 38
D. Carriero, F. Fabrizi, A. Uriel, J. Park, Paul Martin, D. Dieterich (2008)
Treatment of Dialysis Patients with Chronic Hepatitis C Using Pegylated Interferon and Low-Dose RibavirinThe International Journal of Artificial Organs, 31
P. Marcellin, M. Martinot-Peignoux, A. Elias, M. Branger, F. Courtois, R. Level, S. Erlinger, J. Benhamou (1994)
Hepatitis C virus (HCV) viremia in human immunodeficiency virus-seronegative and -seropositive patients with indeterminate HCV recombinant immunoblot assay.The Journal of infectious diseases, 170 2
M. Alter, L. Seeff, B. Bacon, David Thomas, M. Rigsby, A. Bisceglie (2004)
Testing for Hepatitis C Virus Infection Should Be Routine for Persons at Increased Risk for InfectionAnnals of Internal Medicine, 141
M. Briggs, Christiane Baker, Robert Hall, J. Gaziano, D. Gagnon, N. Bzowej, T. Wright (2001)
Prevalence and risk factors for hepatitis C virus infection at an Urban veterans administration medical centerHepatology, 34
X. Forns, M. García-Retortillo, T. Serrano, A. Feliu, F. Suárez, M. Mata, J. García-Valdecasas, M. Navasa, A. Rimola, J. Rodés (2003)
Antiviral therapy of patients with decompensated cirrhosis to prevent recurrence of hepatitis C after liver transplantation.Journal of hepatology, 39 3
C. Rumbo, R. Fawaz, S. Emre, F. Suchy, N. Kerkar, R. Morotti, B. Shneider (2006)
Hepatitis C in Children: A Quaternary Referral Center PerspectiveJournal of Pediatric Gastroenterology and Nutrition, 43
M. Cornberg, J. Hadem, E. Herrmann, F. Schuppert, H. Schmidt, M. Reiser, O. Marschal, M. Steffen, M. Manns, H. Wedemeyer (2006)
Treatment with daily consensus interferon (CIFN) plus ribavirin in non-responder patients with chronic hepatitis C: a randomized open-label pilot study.Journal of hepatology, 44 2
E. Nakayama, T. Akiba, F. Marumo, C. Sato (2000)
Prognosis of anti-hepatitis C virus antibody-positive patients on regular hemodialysis therapy.Journal of the American Society of Nephrology : JASN, 11 10
BrianJ. Pereira, S. Natov, B. Bouthot, B. Murthy, R. Ruthazer, C. Schmid, A. Levey (1998)
Effects of hepatitis C infection and renal transplantation on survival in end-stage renal disease. The New England Organ Bank Hepatitis C Study Group.Kidney international, 53 5
K. Shu, J. Lan, Ming-Ju Wu, Chi-hung Cheng, Chen‐Hsu Chen, Wen-Chin Lee, Horng-Rong Chang, J. Lian (2004)
ULTRALOW-DOSE ALPHA-INTERFERON PLUS RIBAVIRIN FOR THE TREATMENT OF ACTIVE HEPATITIS C IN RENAL TRANSPLANT RECIPIENTSTransplantation, 77
N. Kamar, D. Ribes, J. Izopet, L. Rostaing (2006)
Treatment of hepatitis C virus infection (HCV) after renal transplantation: implications for HCV-positive dialysis patients awaiting a kidney transplant.Transplantation, 82 7
H. Nomura, Suketo Sou, H. Tanimoto, T. Nagahama, Y. Kimura, J. Hayashi, H. Ishibashi, S. Kashiwagi (2004)
Short‐term interferon‐alfa therapy for acute hepatitis C: A randomized controlled trialHepatology, 39
(1990)
Visual Information Specialist
D. Strader, B. Bacon, K. Lindsay, Douglas Brecque, T. Morgan, E. Wright, Jeff Allen, Farooq Khokar, J. Hoofnagle, L. Seeff (2002)
Use of complementary and alternative medicine in patients with liver diseaseAmerican Journal of Gastroenterology, 97
W. Vogel, I. Graziadei, F. Umlauft, C. Datz, F. Hackl, S. Allinger, K. Grünewald, J. Patsch (1996)
High-dose interferon-alpha2b treatment prevents chronicity in acute hepatitis C: a pilot study.Digestive diseases and sciences, 41 12 Suppl
P. Simmonds, J. Bukh, C. Combet, G. Deléage, N. Enomoto, S. Feinstone, P. Halfon, G. Inchauspe, Carla Kuiken, G. Maertens, M. Mizokami, D. Murphy, H. Okamoto, J. Pawlotsky, F. Penin, E. Sablon, T. Shin-I, L. Stuyver, H. Thiel, S. Viazov, A. Weiner, A. Widell (2005)
Consensus proposals for a unified system of nomenclature of hepatitis C virus genotypesHepatology, 42
T. Poynard, V. Ratziu, J. McHutchison, M. Manns, Z. Goodman, S. Zeuzem, Z. Younossi, J. Albrecht (2003)
Effect of treatment with peginterferon or interferon alfa‐2b and ribavirin on steatosis in patients infected with hepatitis CHepatology, 38
E. Gane, S. Lo, S. Riordan, B. Portmann, J. Lau, N. Naoumov, Roger Williams (1998)
A randomized study comparing ribavirin and interferon alfa monotherapy for hepatitis C recurrence after liver transplantationHepatology, 27
J. Guh, Yung-Hsiung Lai, Chi-Yuan Yang, Shinn-Cherng Chen, W. Chuang, Tzu-Chao Hsu, Hung-Chun Chen, Wen-Yu Chang, Juei-Hsiung Tsai (1995)
Impact of decreased serum transaminase levels on the evaluation of viral hepatitis in hemodialysis patients.Nephron, 69 4
J. Westin, L. Lagging, F. Spak, N. Aires, E. Svensson, M. Lindh, A. Dhillon, G. Norkrans, R. Wejstål (2002)
Moderate alcohol intake increases fibrosis progression in untreated patients with hepatitis C virus infectionJournal of Viral Hepatitis, 9
R. Shiffman, P. Shekelle, J. Overhage, J. Slutsky, J. Grimshaw, Aniruddha Deshpande (2003)
Standardized Reporting of Clinical Practice Guidelines: A Proposal from the Conference on Guideline StandardizationAnnals of Internal Medicine, 139
Bruix Bruix, Sherman Sherman (2005)
Management of hepatocellular carcinomaHEPATOLOGY, 42
D. Strader, L. Seeff (1996)
The natural history of chronic hepatitis C infection.European journal of gastroenterology & hepatology, 8 4
M. Koffler (1965)
Epidemiology of hepatitis.Lancet, 2 7417
A. Contreras, I. Ruiz, Gisela Polanco-Cruz, F. Monteon, Alfredo Celis, G. Vázquez, Efraín Gómez-Herrera, Jesús García-Correa, R. Malé-Velázquez, Sara Ruelas-Hernández (2007)
End-stage renal disease and hepatitis C infection: comparison of alanine aminotransferase levels and liver histology in patients with and without renal damage.Annals of hepatology, 6 1
Nina Singh, T. Gayowski, C. Wannstedt, A. Shakil, M. Wagener, J. Fung, I. Marino (1998)
Interferon-α for prophylaxis of recurrent viral hepatitis C in liver transplant recipients : A prospective, randomized, controlled trialTransplantation, 65
A. Licata, D. Bona, F. Schepis, L. Shahied, A. Craxì, C. Cammà (2003)
When and how to treat acute hepatitis C?Journal of hepatology, 39 6
M. Rivera, M. Gentil, M. Sayago, F. Roncero, C. Trigo, G. Algarra, P. Pereira, M. Valdivia, J. Aguilar (2005)
Treatment of hepatitis C virus with interferon in hemodialysis patients awaiting kidney transplant.Transplantation proceedings, 37 3
T. Carlsson, O. Reichard, G. Norkrans, J. Bläckberg, P. Sangfelt, E. Wallmark, O. Weiland (2005)
Hepatitis C virus RNA kinetics during the initial 12 weeks treatment with pegylated interferon‐alpha 2a and ribavirin according to virological responseJournal of Viral Hepatitis, 12
A. Laumann, A. Derick (2006)
Tattoos and body piercings in the United States: a national data set.Journal of the American Academy of Dermatology, 55 3
J. Sánchez‐Tapias, M. Diago, P. Escartín, J. Enríquez, M. Romero‐Gomez, R. Bárcena, J. Crespo, R. Andrade, E. Martínez‐Bauer, R. Pérez, M. Testillano, R. Planas, R. Solá, M. García-Bengoechea, J. García-Samaniego, M. Munoz-Sanchez, R. Moreno-otero (2006)
Peginterferon-alfa2a plus ribavirin for 48 versus 72 weeks in patients with detectable hepatitis C virus RNA at week 4 of treatment.Gastroenterology, 131 2
O. Kokoğlu, H. Uçmak, S. Hoşoğlu, A. Çetinkaya, B. Kantarçeken, M. Buyukbese, I. Işik (2006)
Efficacy and tolerability of pegylated‐interferon alpha‐2a in hemodialysis patients with chronic hepatitis CJournal of Gastroenterology and Hepatology, 21
R. Robinson (2006)
Economic Evaluation and Health Care Cost-effectiveness analysis
P. Manzini, G. Saracco, A. Cerchier, C. Riva, Alberto Musso, E. Ricotti, E. Palomba, C. Scolfaro, G. Verme, F. Bonino, P. Tovo (1995)
Human immunodeficiency virus infection as risk factor for mother‐to‐child hepatitis C virus transmission; Persistence of anti–hepatitis C virus in children is associated with the mother's anti–hepatitis C virus immunoblotting patternHepatology, 21
I. Jacobson, S. Gonzalez, F. Ahmed, E. Lebovics, A. Min, H. Bodenheimer, S. Esposito, Robert Brown, N. Bräu, F. Klion, H. Tobias, E. Bini, N. Brodsky, M. Cerulli, A. Aytaman, Peter Gardner, J. Geders, J. Spivack, M. Rahmin, D. Berman, J. Ehrlich, M. Russo, M. Chait, D. Rovner, B. Edlin (2005)
A Randomized Trial of Pegylated Interferon α-2b Plus Ribavirin in the Retreatment of Chronic Hepatitis CThe American Journal of Gastroenterology, 100
L. Sandrin, B. Fourquet, J. Hasquenoph, S. Yon, C. Fournier, F. Mal, C. Christidis, M. Ziol, B. Poulet, F. Kazemi, M. Beaugrand, R. Palau (2003)
Transient elastography: a new noninvasive method for assessment of hepatic fibrosis.Ultrasound in medicine & biology, 29 12
R. Ghobrial, R. Steadman, J. Gornbein, C. Lassman, C. Holt, Pauline Chen, D. Farmer, H. Yersiz, Natale Danino, E. Collisson, Angeles Baquarizo, S. Han, S. Saab, L. Goldstein, J. Donovan, K. Esrason, R. Busuttil (2001)
A 10-Year Experience of Liver Transplantation for Hepatitis C: Analysis of Factors Determining Outcome in Over 500 PatientsAnnals of Surgery, 234
D. Marcelli, D. Stannard, Ferruccio Conte, P. Held, Francesco Locatelli, F. Port (1996)
ESRD patient mortality with adjustment for comorbid conditions in Lombardy (Italy) versus the United States.Kidney international, 50 3
R. Levine, S. Sanderson, R. Ploutz-Snyder, F. Murray, E. Kay, J. Hegarty, N. Nolan, D. Kelleher, G. McDonald, J. O’keane, J. Crowe (2006)
Assessment of fibrosis progression in untreated irish women with chronic hepatitis C contracted from immunoglobulin anti-D.Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association, 4 10
(2007)
Clin Liver Dis
M. Persico, E. Persico, R. Suozzo, Salvatore Conte, Massimiliano Seta, L. Coppola, Bruno Palmentieri, F. Sasso, R. Torella (2000)
Natural history of hepatitis C virus carriers with persistently normal aminotransferase levels.Gastroenterology, 118 4
M. Shiffman, F. Suter, B. Bacon, D. Nelson, H. Harley, R. Solá, S. Shafran, K. Barange, A. Lin, A. Soman, S. Zeuzem (2007)
Peginterferon alfa-2a and ribavirin for 16 or 24 weeks in HCV genotype 2 or 3.The New England journal of medicine, 357 2
M. Wagner, M. Huber, T. Berg, H. Hinrichsen, J. Rasenack, T. Heintges, A. Bergk, C. Bernsmeier, D. Häussinger, E. Herrmann, S. Zeuzem (2005)
Peginterferon-α-2a (40KD) and Ribavirin for 16 or 24 Weeks in Patients With Genotype 2 or 3 Chronic Hepatitis CGastroenterology, 129
L. Seeff, J. Hoofnagle (2002)
National Institutes of Health Consensus Development Conference: Management of Hepatitis C: 2002Hepatology, 36
F. Fabrizi, F. Poordad, Paul Martin (2002)
Hepatitis C infection and the patient with end‐stage renal diseaseHepatology, 36
G. Basse, D. Ribes, N. Kamar, M. Mehrenberger, L. Esposito, J. Guitard, L. Lavayssière, F. Oksman, D. Dur, L. Rostaing (2005)
Rituximab Therapy for De Novo Mixed Cryoglobulinemia in Renal Transplant PatientsTransplantation, 80
L. Jeffers, W. Cassidy, C. Howell, S. Hu, K. Reddy (2004)
Peginterferon alfa‐2a (40 kd) and ribavirin for black American patients with chronic HCV genotype 1Hepatology, 39
V. Agnello, R. Chung, L. Kaplan (1992)
A role for hepatitis C virus infection in type II cryoglobulinemia.The New England journal of medicine, 327 21
H. El‐Serag (2004)
Hepatocellular carcinoma: recent trends in the United States.Gastroenterology, 127 5 Suppl 1
P. Sheiner, P. Boros, F. Klion, S. Thung, L. Schluger, J. Lau, E. Mor, C. Bodian, S. Guy, M. Schwartz, S. Emre, Henry Bodenheer, Charles Miller (1998)
The efficacy of prophylactic interferon alfa‐2b in preventing recurrent hepatitis C after liver transplantationHepatology, 28
P. Pockros, M. Shiffman, E. Schiff, M. Sulkowski, Z. Younossi, D. Dieterich, T. Wright, S. Mody, K. Tang, B. Goon, P. Bowers, G. Leitz, N. Afdhal (2004)
Epoetin alfa improves quality of life in anemic HCV‐infected patients receiving combination therapyHepatology, 40
T. Wright, T. Wright, T. Wright, E. Donegan, E. Donegan, E. Donegan, H. Hsu, H. Hsu, H. Hsu, L. Ferrell, L. Ferrell, L. Ferrell, J. Lake, J. Lake, J. Lake, Michael Kim, Michael Kim, Michael Kim, C. Combs, C. Combs, C. Combs, S. Fennessy, S. Fennessy, S. Fennessy, J. Roberts, J. Roberts, J. Roberts, N. Ascher, N. Ascher, N. Ascher, H. Greenberg, H. Greenberg, H. Greenberg (1992)
Recurrent and acquired hepatitis C viral infection in liver transplant recipients.Gastroenterology, 103 1
E. Chamot, B. Hirschel, J. Wintsch, C. Robert, V. Gabriel, J. Déglon, S. Yerly, L. Perrin (1990)
Loss of antibodies against hepatitis C virus in HIV-seropositive intravenous drug users.AIDS, 4 12
D. Brophy, E. Martin, S. Carr, B. Kirschbaum, M. Carr (2007)
The effect of uremia on platelet contractile force, clot elastic modulus and bleeding time in hemodialysis patients.Thrombosis research, 119 6
K. Batts, J. Ludwig (1995)
Chronic hepatitis. An update on terminology and reporting.The American journal of surgical pathology, 19 12
G. Garini, L. Allegri, L. Carnevali, W. Catellani, P. Manganelli, C. Buzio (2001)
Interferon-alpha in combination with ribavirin as initial treatment for hepatitis C virus-associated cryoglobulinemic membranoproliferative glomerulonephritis.American journal of kidney diseases : the official journal of the National Kidney Foundation, 38 6
(2007)
Surveillance for acute viral hepatitis--United States, 2005.
D. Dufour, J. Lott, F. Nolte, D. Gretch, R. Koff, L. Seeff (2000)
Diagnosis and monitoring of hepatic injury. I. Performance characteristics of laboratory tests.Clinical chemistry, 46 12
K. Kalantar-Zadeh, L. Miller, E. Daar (2005)
Diagnostic discordance for hepatitis C virus infection in hemodialysis patients.American journal of kidney diseases : the official journal of the National Kidney Foundation, 46 2
A. Soza, J. Everhart, M. Ghany, E. Doo, T. Heller, K. Promrat, Y. Park, T. Liang, J. Hoofnagle (2002)
Neutropenia during combination therapy of interferon alfa and ribavirin for chronic hepatitis CHepatology, 36
Cristina Rocha, R. Perez, A. Ferreira, R. Carvalho-Filho, F. Pace, I. Silva, J. Pestana, V. Lanzoni, Antonio Silva, M. Ferraz (2006)
Efficacy and tolerance of interferon‐α in the treatment of chronic Hepatitis C in end‐stage renal disease patients on hemodialysisLiver International, 26
Sandro Vento, T. Garofano, C. Renzini, F. Cainelli, F. Casali, G. Ghironzi, T. Ferraro, E. Concia (1998)
Fulminant hepatitis associated with hepatitis A virus superinfection in patients with chronic hepatitis C.The New England journal of medicine, 338 5
T. Chan, S. Ho, C. Tang, K. Tse, M. Lam, K. Lai, S. Yung (2007)
Pilot study of pegylated interferon‐alpha 2a in dialysis patients with chronic hepatitis C virus infectionNephrology, 12
H. Ohto, S. Terazawa, N. Sasaki, Nobutaka Sasaki, K. Hino, C. Ishiwata, M. Kako, N. Ujiie, C. Endo, A. Matsui, H. Okamoto, S. Mishiro (1994)
Transmission of Hepatitis C Virus From Mothers to InfantsObstetrical & Gynecological Survey, 49
M. Jadoul, C. Cornu, C. Strihou (1998)
Universal precautions prevent hepatitis C virus transmission: a 54 month follow-up of the Belgian Multicenter Study. The Universitaires Cliniques St-Luc (UCL) Collaborative Group.Kidney international, 53 4
M. Russo, R. Ghalib, S. Sigal, V. Joshi (2006)
Randomized trial of pegylated interferon alpha-2b monotherapy in haemodialysis patients with chronic hepatitis C.Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 21 2
H. Alter, L. Seeff (2000)
Recovery, Persistence, and Sequelae in Hepatitis C Virus Infection: A Perspective on Long-Term OutcomeSEMINARS IN LIVER DISEASE, Volume 20
M. Russo, C. Goldsweig, I. Jacobson, Robert Brown (2003)
Interferon monotherapy for dialysis patients with chronic hepatitis C: an analysis of the literature on efficacy and safetyAmerican Journal of Gastroenterology, 98
M. Alter (2002)
Prevention of spread of hepatitis CHepatology, 36
C. Puoti, M. Guido, A. Mangia, M. Persico, D. Prati (2003)
Clinical management of HCV carriers with normal aminotransferase levels.Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver, 35 5
T. Bino, Z. Madar, A. Gertler, H. Rosenberg (1982)
The kidney is the main site of interferon degradation.Journal of interferon research, 2 2
C. Puoti, A. Magrini, T. Stati, P. Rigato, F. Montagnese, P. Rossi, L. Aldegheri, S. Resta (1997)
Clinical, histological, and virological features of hepatitis C virus carriers with persistently normal or abnormal alanine transaminase levelsHepatology, 26
C. Camarero, N. Ramos, A. Moreno, A. Asensio, M. Mateos, B. Roldán (2007)
Hepatitis C virus infection acquired in childhoodEuropean Journal of Pediatrics, 167
E. Jaeckel, M. Cornberg, H. Wedemeyer, T. Santantonio, Julika Mayer, Myrga Zankel, Giuseppe Pastore, Manfred Dietrich, Christiane Trautwein, Michael Manns (2001)
Treatment of acute hepatitis C with interferon alfa-2b.The New England journal of medicine, 345 20
J. Duclos‐Vallée, C. Féray, M. Sebagh, E. Teicher, A. Roque-Afonso, B. Roche, D. Azoulay, R. Adam, H. Bismuth, D. Castaing, D. Vittecoq, D. Samuel (2007)
Survival and recurrence of hepatitis C after liver transplantation in patients coinfected with human immunodeficiency virus and hepatitis C virusHepatology, 47
F. Bortolotti, P. Vajro, P. Cadrobbi, L. Lepore, L. Zancan, C. Barbera, C. Crivellaro, A. Fontanella, A. Alberti, M. D'Addezio (1992)
Cryptogenic chronic liver disease and hepatitis C virus infection in children.Journal of hepatology, 15 1-2
C. Conry-Cantilena, M. Vanraden, J. Gibble, J. Melpolder, A. Shakil, L. Viladomiu, L. Cheung, A. Dibisceglie, J. Hoofnagle, J. Shih, R. Kaslow, P. Ness, H. Alter (1996)
Routes of infection, viremia, and liver disease in blood donors found to have hepatitis C virus infection.The New England journal of medicine, 334 26
A. Regev, M. Berho, L. Jeffers, C. Milikowski, E. Molina, N. Pyrsopoulos, Zheng Feng, K. Reddy, E. Schiff (2002)
Sampling error and intraobserver variation in liver biopsy in patients with chronic HCV infectionAmerican Journal of Gastroenterology, 97
T. Poynard, P. Bedossa, P. Opolon, Metavir OBSVIRC (1997)
Natural history of liver fibrosis progression in patients with chronic hepatitis CThe Lancet, 349
L. Capuron, Jane Gumnick, D. Musselman, D. Lawson, A. Reemsnyder, C. Nemeroff, Andrew Miller (2002)
Neurobehavioral Effects of Interferon-α in Cancer Patients: Phenomenology and Paroxetine Responsiveness of Symptom DimensionsNeuropsychopharmacology, 26
D. Conte, M. Fraquelli, D. Prati, A. Colucci, E. Minola (2000)
Prevalence and clinical course of chronic hepatitis C virus (HCV) infection and rate of HCV vertical transmission in a cohort of 15,250 pregnant womenHepatology, 31
S. Tang, K. Lai (2005)
Chronic viral hepatitis in hemodialysis patientsHemodialysis International, 9
B. Antoszewski, A. Sitek, Marta Jędrzejczak, A. Kasielska, J. Kruk‐Jeromin (2006)
Are body piercing and tattooing safe fashions?European journal of dermatology : EJD, 16 5
J. Crippin, T. Mccashland, N. Terrault, P. Sheiner, M. Charlton (2002)
A pilot study of the tolerability and efficacy of antiviral therapy in hepatitis C virus–infected patients awaiting liver transplantationLiver Transplantation, 8
M. Laguno, J. Murillas, J. Blanco, E. Martinez, R. Miquel, J. Sánchez‐Tapias, X. Bargalló, Á. García-Criado, E. Lazzari, M. Larrousse, A. León, M. Loncá, A. Milinkovic, J. Gatell, J. Mallolas (2004)
Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for treatment of HIV/HCV co-infected patientsAIDS, 18
A. Sagir, A. Erhardt, M. Schmitt, D. Häussinger (2007)
Transient elastography is unreliable for detection of cirrhosis in patients with acute liver damageHepatology, 47
G. Taliani, G. Gemignani, C. Ferrari, A. Aceti, D. Bartolozzi, P. Blanc, M. Capanni, F. Esperti, P. Forte, V. Guadagnino, T. Mari, N. Marino, S. Milani, C. Pasquazzi, F. Rosina, D. Tacconi, M. Toti, A. Zignego, L. Messerini, T. Stroffolini (2006)
Pegylated interferon alfa-2b plus ribavirin in the retreatment of interferon-ribavirin nonresponder patients.Gastroenterology, 130 4
K. Lindahl, L. Ståhle, A. Bruchfeld, R. Schvarcz (2005)
High‐dose ribavirin in combination with standard dose peginterferon for treatment of patients with chronic hepatitis CHepatology, 41
S. Fagiuoli, D. Cooper, N. Zuhdi (1998)
Hepatitis C status of heart transplant recipients.Clinical transplantation, 12 1
T. Wiley, M. McCarthy, Lama Breidi, M. McCarthy, T. Layden (1998)
Impact of alcohol on the histological and clinical progression of Hepatitis C infectionHepatology, 28
S. Boccato, R. Pistis, F. Noventa, M. Guido, L. Benvegnu', A. Alberti (2006)
Fibrosis progression in initially mild chronic hepatitis CJournal of Viral Hepatitis, 13
Hepatitis Hepatitis, virus virus (1998)
American Academy of PediatricsPediatrics, 101
Eddy (1996)
1
P. Pradat, A. Alberti, T. Poynard, J. Esteban, O. Weiland, P. Marcellin, S. Badalamenti, C. Trépo (2002)
Predictive value of ALT levels for histologic findings in chronic hepatitis C: A European collaborative studyHepatology, 36
P. Scheuer (1991)
Classification of chronic viral hepatitis: a need for reassessment.Journal of hepatology, 13 3
A. Lafeuillade, G. Hittinger, S. Chadapaud (2001)
Increased mitochondrial toxicity with ribavirin in HIV/HCV coinfectionThe Lancet, 357
G. Reiss, E. Keeffe (2005)
Role of liver biopsy in the management of chronic liver disease: selective rather than routine.Reviews in gastroenterological disorders, 5 4
M. Sorrell, E. Belongia, José Costa, I. Gareen, J. Grem, J. Inadomi, E. Kern, J. McHugh, G. Petersen, M. Rein, D. Strader, H. Trotter (2009)
National Institutes of Health Consensus Development Conference Statement: management of hepatitis B.Annals of internal medicine, 150 2
I. Bica, B. McGovern, R. Dhar, D. Stone, K. McGowan, R. Scheib, D. Snydman (2001)
Increasing mortality due to end-stage liver disease in patients with human immunodeficiency virus infection.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 32 3
P. Bonis (1999)
Clinical outcomes after hepatitis C infection from contaminated anti-D immune globulin.The New England journal of medicine, 341 10
R. Firpi, Haizhen Zhu, G. Morelli, M. Abdelmalek, C. Soldevila‐Pico, V. Machicao, R. Cabrera, A. Reed, Chen Liu, D. Nelson (2006)
Cyclosporine suppresses hepatitis C virus in vitro and increases the chance of a sustained virological response after liver transplantationLiver Transplantation, 12
S. Montgomery, M. Åsberg (1979)
A New Depression Scale Designed to be Sensitive to ChangeBritish Journal of Psychiatry, 134
Martin Martin, Carter Carter, Fabrizi Fabrizi, Dixit Dixit, Conrad Conrad, Artinian Artinian (2000)
Histopathological features of hepatitis C in renal transplant candidatesTransplantation, 69
F. Roudot-thoraval, J. Pawlotsky, V. Thiers, L. Deforges, P. Girollet, François Guillot, C. Huraux, P. Aumont, C. Bréchot, D. Dhumeaux (1993)
Lack of mother‐to‐infant transmission of hepatitis C virus in human immunodeficiency virus–seronegative women: A prospective study with hepatitis C virus RNA testingHepatology, 17
D. Rockey, S. Caldwell, Z. Goodman, R. Nelson, Alastair Smith (2008)
AASLD position paper: Liver biopsyHepatology
M. Berenguer, M. Prieto, A. Palau, D. Carrasco, J. Rayón, F. Calvo, J. Berenguer (2004)
Recurrent hepatitis C genotype 1b following liver transplantation: treatment with combination interferon–ribavirin therapyEuropean Journal of Gastroenterology & Hepatology, 16
F. Bortolotti, R. Giacchino, P. Vajro, C. Barbera, C. Crivellaro, A. Alberti, G. Nebbia, L. Zancan, L. Moliner, A. Bertolini, F. Balli, F. Callea (1995)
Recombinant interferon‐alfa therapy in children with chronic hepatitis CHepatology, 22
P. Hoggard, S. Kewn, M. Barry, S. Khoo, D. Back (1997)
Effects of drugs on 2',3'-dideoxy-2',3'-didehydrothymidine phosphorylation in vitroAntimicrobial Agents and Chemotherapy, 41
A. Wasley (1999)
Prevention of hepatitis A through active or passive immunization: Recommendations of the Advisory Committee on Immunization Practices (ACIP).MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports, 48 RR-12
L. Castells, V. Vargas, H. Allende, I. Bilbao, José Lázaro, C. Margarit, R. Esteban, J. Guardia (2005)
Combined treatment with pegylated interferon (alpha-2b) and ribavirin in the acute phase of hepatitis C virus recurrence after liver transplantation.Journal of hepatology, 43 1
R. Gonzalez-Peralta, D. Kelly, B. Haber, J. Molleston, K. Murray, M. Jonas, M. Shelton, G. Mieli-Vergani, Y. Lurie, Steven Martin, T. Lang, Andrew Baczkowski, M. Geffner, Samir Gupta, M. Laughlin (2005)
Interferon alfa‐2b in combination with ribavirin for the treatment of chronic hepatitis C in children: Efficacy, safety, and pharmacokineticsHepatology, 42
M. Alter, H. Margolis (1998)
Recommendations for prevention and control of hepatitis C virus (HCV) infection and HCV-related chronic disease
V. Bocci, A. Pacini, M. Muscettola, L. Paulesu, G. Pessina, M. Santiano, I. Viano (1981)
Renal filtration, absorption and catabolism of human alpha interferon.Journal of interferon research, 1 3
M. Schaefer, F. Schmidt, C. Folwaczny, R. Lorenz, G. Martin, N. Schindlbeck, W. Heldwein, M. Soyka, H. Grunze, A. Koenig, K. Loeschke (2003)
Adherence and mental side effects during hepatitis C treatment with interferon alfa and ribavirin in psychiatric risk groupsHepatology, 37
N. Furusyo, J. Hayashi, Yoko Kanamoto-Tanaka, I. Ariyama, Y. Etoh, Masaru Shigematsu, S. Kashiwagi (2000)
Liver Damage in Hemodialysis Patients with Hepatitis C Virus Viremia: A Prospective 10-Year StudyDigestive Diseases and Sciences, 45
M. Berenguer, A. Palau, A. Fernández, S. Benlloch, V. Aguilera, M. Prieto, J. Rayón, J. Berenguer (2006)
Efficacy, predictors of response, and potential risks associated with antiviral therapy in liver transplant recipients with recurrent hepatitis CLiver Transplantation, 12
(1996)
A manual for assessing health practices and designing practice guidelines. Philadelphia. American College of Physicians
Ryan Thomas, J. Brems, G. Guzman-Hartman, S. Yong, P. Cavaliere, D. Thiel (2003)
Infection with chronic hepatitis C virus and liver transplantation: A role for interferon therapy before transplantationLiver Transplantation, 9
N. Terrault (2002)
Sexual activity as a risk factor for hepatitis CHepatology, 36
S. Mehta, A. Cox, D. Hoover, Xiao-hong Wang, Q. Mao, S. Ray, S. Strathdee, D. Vlahov, David Thomas (2002)
Protection against persistence of hepatitis CThe Lancet, 359
Ranga Balasekaran, M. Bulterys, M. Jamal, P. Quinn, D. Johnston, B. Skipper, Sanjana Chaturvedi, Sanjeev Arora (1999)
A case-control study of risk factors for sporadic hepatitis C virus infection in the southwestern United StatesAmerican Journal of Gastroenterology, 94
S. Bellentani, G. Pozzato, G. Saccoccio, M. Crovatto, L. Crocè, L. Mazzoran, F. Masutti, G. Cristianini, C. Tiribelli (1999)
Clinical course and risk factors of hepatitis C virus related liver disease in the general population: report from the Dionysos studyGut, 44
B. Christensson, T. Wiebe, A. Åkesson, A. Widell (2000)
Interferon-alpha and ribavirin treatment of hepatitis C in children with malignancy in remission.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 30 3
I. Sporea, A. Popescu, R. Șirli, O. Golea, Camelia Totolici, M. Danila, C. Vernic (2006)
Pegylated-interferon alpha 2a treatment for chronic hepatitis C in patients on chronic haemodialysis.World journal of gastroenterology, 12 26
G. Schreiber, M. Busch, S. Kleinman, J. Korelitz (1996)
The risk of transfusion-transmitted viral infections. The Retrovirus Epidemiology Donor Study.The New England journal of medicine, 334 26
A. Iacobellis, M. Siciliano, F. Perri, B. Annicchiarico, G. Leandro, N. Caruso, L. Accadia, G. Bombardieri, A. Andriulli (2007)
Peginterferon alfa-2b and ribavirin in patients with hepatitis C virus and decompensated cirrhosis: a controlled study.Journal of hepatology, 46 2
A. Covic, I. Maftei, N. Mardare, F. Ioniță-Radu, Camelia Totolici, L. Tuta, O. Golea, M. Covic, C. Volovăţ, P. Gusbeth-tatomir, G. Mircescu (2006)
Analysis of safety and efficacy of pegylated-interferon alpha-2a in hepatitis C virus positive hemodialysis patients: results from a large, multicenter audit.Journal of nephrology, 19 6
L. Seeff (1997)
Natural history of hepatitis CHepatology, 26
E. Otón, R. Bárcena, J. Moreno-Planas, V. Cuervas-Mons, A. Moreno-Zamora, C. Barrios, S. García-Garzón, A. Moreno, E. Boullosa-Graña, E. Rubio-González, M. García‐González, C. Blesa, M. Mateos (2006)
Hepatitis C Recurrence After Liver Transplantation: Viral and Histologic Response to Full‐Dose Peg‐Interferon and RibavirinAmerican Journal of Transplantation, 6
J. Germer, P. Rys, J. Thorvilson, D. Persing (1999)
Determination of Hepatitis C Virus Genotype by Direct Sequence Analysis of Products Generated with the Amplicor HCV TestJournal of Clinical Microbiology, 37
H. Fontaine, B. Nalpas, B. Poulet, F. Carnot, H. Zylberberg, C. Bréchot, S. Pol (2001)
Hepatitis activity index is a key factor in determining the natural history of chronic hepatitis C.Human pathology, 32 9
S. Zeuzem, C. Welsch, E. Herrmann (2003)
Pharmacokinetics of PeginterferonsSEMINARS IN LIVER DISEASE, 23
C. Colin, D. Lanoir, S. Touzet, L. Meyaud-Kraemer, F. Bailly, C. Trépo (2001)
Sensitivity and specificity of third‐generation hepatitis C virus antibody detection assays: an analysis of the literatureJournal of Viral Hepatitis, 8
D. Jensen, T. Morgan, P. Marcellin, P. Pockros, K. Reddy, S. Hadziyannis, P. Ferenci, A. Ackrill, B. Willems (2006)
Early identification of HCV genotype 1 patients responding to 24 weeks peginterferon α‐2a (40 kd)/ribavirin therapyHepatology, 43
F. Fabrizi, G. Lunghi, S. Finazzi, P. Colucci, Antonio Pagano, Claudio Ponticelli, Francesco Locatelli (2001)
Decreased serum aminotransferase activity in patients with chronic renal failure: impact on the detection of viral hepatitis.American journal of kidney diseases : the official journal of the National Kidney Foundation, 38 5
Lionel Rostaing, Etienne Chatelut, J.L. Payen, Jacques Izopet, Claire Thalamas, H. Ton-That, Jean-Pierre Pascal, Dominique Durand, Pierre Canal (1998)
Pharmacokinetics of alphaIFN-2b in chronic hepatitis C virus patients undergoing chronic hemodialysis or with normal renal function: clinical implications.Journal of the American Society of Nephrology : JASN, 9 12
Obert, W. A., Olfe, Alarie, A. B., Shby, Dgar, M. L., Ilford, Kinlolu, O. O., Jo, E. E., Ttenger, Awrence, A. Y.C., Godoa, Hilip, H. J., Eld (2000)
COMPARISON OF MORTALITY IN ALL PATIENTS ON DIALYSIS , PATIENTS ON DIALYSIS AWAITING TRANSPLANTATION , AND RECIPIENTS OF A FIRST CADAVERIC TRANSPLANT
Gale Burstein, K. Workowski (2003)
Sexually transmitted diseases treatment guidelinesCurrent Opinion in Pediatrics, 15
G. Corrao, S. Aricó (1998)
Independent and combined action of hepatitis C virus infection and alcohol consumption on the risk of symptomatic liver cirrhosisHepatology, 27
Combination of interferon alfa - 2 b and ribavirin in
Aijaz Ahmed, E. Keeffe (2004)
Chronic hepatitis C with normal aminotransferase levels.Gastroenterology, 126 5
A. Mangia, R. Santoro, N. Minerva, G. Ricci, Vito Carretta, M. Persico, F. Vinelli, G. Scotto, D. Bacca, M. Annese, M. Romano, F. Zechini, Fernando Sogari, F. Spirito, A. Andriulli (2005)
Peginterferon alfa-2b and ribavirin for 12 vs. 24 weeks in HCV genotype 2 or 3.The New England journal of medicine, 352 25
C. Graham, L. Baden, E. Yu, J. Mrus, J. Carnie, Timothy Heeren, M. Koziel (2001)
Influence of human immunodeficiency virus infection on the course of hepatitis C virus infection: a meta-analysis.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 33 4
Sandro Vento (2000)
Fulminant hepatitis associated with hepatitis A virus superinfection in patients with chronic hepatitis CJournal of Viral Hepatitis, 7
D. Saadoun, M. Resche-Rigon, V. Thibault, J. Piette, P. Cacoub (2006)
Antiviral therapy for hepatitis C virus--associated mixed cryoglobulinemia vasculitis: a long-term followup study.Arthritis and rheumatism, 54 11
J. Saldanha, N. Lelie, A. Heath (1999)
Establishment of the First International Standard for Nucleic Acid Amplification Technology (NAT) Assays for HCV RNAVox Sanguinis, 76
S. Kamal, S. Kamary, M. Shardell, M. Hashem, Imad Ahmed, Mohamed Muhammadi, K. Sayed, Ashraf Moustafa, Sarah Hakem, Amany Ibrahiem, M. Moniem, H. Mansour, M. Abdelaziz (2007)
Pegylated interferon alpha‐2b plus ribavirin in patients with genotype 4 chronic hepatitis C: The role of rapid and early virologic responseHepatology, 46
P. Farci, H. Alter, S. Govindarajan, D. Wong, R. Engle, R. Lesniewski, I. Mushahwar, S. Desai, R. Miller, N. Ogata (1993)
Lack of protective immunity against reinfection with hepatitis C virus.Science, 258 5079
K. Noda, H. Yoshihara, Kunio Suzuki, Y. Yamada, A. Kasahara, N. Hayashi, H. Fusamoto, T. Kamada (1996)
Progression of type C chronic hepatitis to liver cirrhosis and hepatocellular carcinoma--its relationship to alcohol drinking and the age of transfusion.Alcoholism, clinical and experimental research, 20 1 Suppl
Cadranel Cadranel, Rufat Rufat, Degos Degos (2000)
Practices of liver biopsy in France: results of a prospective nationwide survey. For the Group of Epidemiology of the French Association for the Study of the Liver (AFEF)HEPATOLOGY, 32
Michael Stein, Jinana Maksad, Jennifer Clarke (2001)
Hepatitis C disease among injection drug users: knowledge, perceived risk and willingness to receive treatment.Drug and alcohol dependence, 61 3
R. Stravitz, M. Shiffman, A. Sanyal, V. Luketic, R. Sterling, D. Heuman, A. Ashworth, A. Mills, M. Contos, A. Cotterell, D. Maluf, M. Posner, R. Fisher (2004)
Effects of interferon treatment on liver histology and allograft rejection in patients with recurrent hepatitis C following liver transplantationLiver Transplantation, 10
Ming‐Lung Yu, C. Dai, Li‐Po Lee, Nei‐Jen Hou, M. Hsieh, Jee‐Fu Huang, Zu-Yau Lin, Shinn-Cherng Chen, M. Hsieh, L. Wang, W. Chang, W. Chuang (2006)
A 24‐week course of high‐dose interferon‐α plus ribavirin for Taiwanese chronic hepatitis C patients with persistently normal or near‐normal alanine aminotransferase levelsLiver International, 26
P. Glue, J. Fang, R. Rouzier-Panis, C. Raffanel, R. Sabo, S. Gupta, M. Salfi, S. Jacobs (2000)
Pegylated interferon-alpha2b: pharmacokinetics, pharmacodynamics, safety, and preliminary efficacy data. Hepatitis C Intervention Therapy Group.Clinical pharmacology and therapeutics, 68 5
Rachana Kumar, Rachana Kumar, S. Shahul, S. Shahul (1998)
Role of breast-feeding in transmission of hepatitis C virus to infants of HCV-infected mothers.Journal of hepatology, 29 2
D. Harris, René Gonin, H. Alter, E. Wright, Zelma Buskell, F. Hollinger, L. Seeff (2001)
The Relationship of Acute Transfusion-Associated Hepatitis to the Development of Cirrhosis in the Presence of Alcohol AbuseAnnals of Internal Medicine, 134
L. Rubbia-Brandt, P. Fabris, S. Paganin, G. Leandro, P. Male, E. Giostra, A. Carlotto, L. Bozzola, A. Smedile, Francesco Negro (2004)
Steatosis affects chronic hepatitis C progression in a genotype specific wayGut, 53
M. Backmund, K. Meyer, B. Edlin (2004)
Infrequent reinfection after successful treatment for hepatitis C virus infection in injection drug users.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 39 10
M. Sulkowski (2007)
The HIV-coinfected patient: managing viral hepatitis.Journal of acquired immune deficiency syndromes, 45 Suppl 2
Seeff Seeff (2007)
Herbal hepatotoxicityClin Liver Dis, 11
L. Hwang, J. Kramer, C. Troisi, L. Bull, C. Grimes, R. Lyerla, M. Alter (2006)
Relationship of cosmetic procedures and drug use to hepatitis C and hepatitis B virus infections in a low‐risk populationHepatology, 44
Paul Martin, D. Carter, F. Fabrizi, V. Dixit, A. Conrad, L. Artinian, Val Peacock, Steven Han, A. Wilkinson, C. Lassman, G. Danovitch (2000)
Histopathological features of hepatitis C in renal transplant candidates [see comment].Transplantation, 69 7
E. Murphy, S. Bryzman, Williams Ae (1999)
Prevalence of hepatitis C virus infection in the United States.The New England journal of medicine, 341 27
G. Matzke, G. Aronoff, A. Atkinson, W. Bennett, B. Decker, K. Eckardt, T. Golper, D. Grabe, B. Kasiske, F. Keller, J. Kielstein, R. Mehta, B. Mueller, D. Pasko, F. Schaefer, D. Sica, L. Inker, J. Umans, P. Murray (2011)
Drug dosing consideration in patients with acute and chronic kidney disease-a clinical update from Kidney Disease: Improving Global Outcomes (KDIGO).Kidney international, 80 11
F. Palella, K. Delaney, A. Moorman, M. Loveless, J. Fuhrer, G. Satten, D. Aschman, S. Holmberg (1998)
Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators.The New England journal of medicine, 338 13
S. Mukherjee, E. Lyden, T. Mccashland, D. Schafer (2005)
Interferon alpha 2b and ribavirin for the treatment of recurrent hepatitis C after liver transplantation: Cohort study of 38 patientsJournal of Gastroenterology and Hepatology, 20
D. Prati, E. Taioli, A. Zanella, E. Torre, S. Butelli, E. Vecchio, L. Vianello, F. Zanuso, F. Mozzi, S. Milani, D. Conte, M. Colombo, G. Sirchia (2002)
Updated Definitions of Healthy Ranges for Serum Alanine Aminotransferase LevelsAnnals of Internal Medicine, 137
P. Labarga, V. Soriano, M. Vispo, J. Pinilla, L. Martín-Carbonero, C. Castellares, R. Casado, I. Maida, P. García-Gascó, P. Barreiro (2007)
Hepatotoxicity of antiretroviral drugs is reduced after successful treatment of chronic hepatitis C in HIV-infected patients.The Journal of infectious diseases, 196 5
G. D’Amico (1998)
Renal involvement in hepatitis C infection: cryoglobulinemic glomerulonephritis.Kidney international, 54 2
L. Castéra, J. Vergniol, J. Foucher, B. Bail, E. Chanteloup, M. Haaser, M. Darriet, P. Couzigou, V. Lédinghen (2005)
Prospective comparison of transient elastography, Fibrotest, APRI, and liver biopsy for the assessment of fibrosis in chronic hepatitis C.Gastroenterology, 128 2
R. Firpi, M. Abdelmalek, C. Soldevila‐Pico, A. Reed, A. Hemming, R. Howard, W. Werf, Gregory Lauwers, Chen Liu, J. Crawford, G. Davis, D. Nelson (2002)
Combination of interferon alfa‐2b and ribavirin in liver transplant recipients with histological recurrent hepatitis CLiver Transplantation, 8
S. Zeuzem, M. Buti, P. Ferenci, J. Sperl, Y. Horsmans, J. Cianciara, E. Ibrányi, O. Weiland, S. Noviello, C. Brass, J. Albrecht (2006)
Efficacy of 24 weeks treatment with peginterferon alfa-2b plus ribavirin in patients with chronic hepatitis C infected with genotype 1 and low pretreatment viremia.Journal of hepatology, 44 1
S. Kamal, A. Fouly, R. Kamel, B. Hockenjos, A. Tawil, K. Khalifa, Qi He, M. Koziel, Khairy Naggar, J. Rasenack, N. Afdhal (2006)
Peginterferon alfa-2b therapy in acute hepatitis C: impact of onset of therapy on sustained virologic response.Gastroenterology, 130 3
M. Berenguer, M. Prieto, J. Rayón, J. Mora, M. Pastor, V. Ortiz, D. Carrasco, F. Juan, M. Burgueño, J. Mir, J. Berenguer (2000)
Natural history of clinically compensated hepatitis C virus–related graft cirrhosis after liver transplantationHepatology, 32
M. Alter, W. Kuhnert, L. Finelli (2003)
Guidelines for laboratory testing and result reporting of antibody to hepatitis C virus. Centers for Disease Control and Prevention.MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports, 52 RR-3
S. Hadziyannis, H. Sette, T. Morgan, V. Balan, M. Diago, P. Marcellin, G. Ramadori, H. Bodenheimer, D. Bernstein, M. Rizzetto, S. Zeuzem, P. Pockros, A. Lin, A. Ackrill (2004)
Peginterferon-alpha2a and ribavirin combination therapy in chronic hepatitis C: a randomized study of treatment duration and ribavirin dose.Annals of internal medicine, 140 5
H. Ohto, S. Terazawa, N. Sasaki, K. Hino, C. Ishiwata, M. Kako, N. Ujiie, C. Endo, A. Matsui (1994)
Transmission of hepatitis C virus from mothers to infants. The Vertical Transmission of Hepatitis C Virus Collaborative Study Group.The New England journal of medicine, 330 11
F. Torriani, M. Rodríguez-Torres, J. Rockstroh, E. Lissen, J. González-García, A. Lazzarin, G. Carosi, J. Sasadeusz, C. Katlama, J. Montaner, H. Sette, S. Passe, J. Pamphilis, F. Duff, U. Schrenk, D. Dieterich (2004)
Peginterferon Alfa-2a plus ribavirin for chronic hepatitis C virus infection in HIV-infected patients.The New England journal of medicine, 351 5
G. Markowitz, J. Cheng, R. Colvin, W. Trebbin, V. D’Agati (1998)
Hepatitis C viral infection is associated with fibrillary glomerulonephritis and immunotactoid glomerulopathy.Journal of the American Society of Nephrology : JASN, 9 12
Richard Rio, A. Post, M. Singer (2006)
Cost‐effectiveness of hematologic growth factors for anemia occurring during hepatitis C combination therapyHepatology, 44
M. Khuroo, M. Khuroo, S. Dahab (2004)
Meta‐analysis: a randomized trial of peginterferon plus ribavirin for the initial treatment of chronic hepatitis C genotype 4Alimentary Pharmacology & Therapeutics, 20
A. Maclean, S. Cameron, E. Follett (1993)
Prevalence of hepatitis B and C viruses and human immunodeficiency virus infections in women of reproductive age.British journal of obstetrics and gynaecology, 100 7
S. Haji, R. Starling, R. Avery, S. Mawhorter, E. Tuzcu, P. Schoenhagen, D. Cook, N. Ratliff, P. McCarthy, James Young, M. Yamani (2004)
Donor hepatitis-C seropositivity is an independent risk factor for the development of accelerated coronary vasculopathy and predicts outcome after cardiac transplantation.The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation, 23 3
M. Berenguer, L. Ferrell, J. Watson, M. Prieto, Michael Kim, M. Rayón, J. Córdoba, A. Herola, N. Ascher, J. Mir, J. Berenguer, T. Wright (2000)
HCV-related fibrosis progression following liver transplantation: increase in recent years.Journal of hepatology, 32 4
S. Wirth, Heidrun Pieper-Boustani, T. Lang, A. Ballauff, Ulrike Kullmer, P. Gerner, P. Wintermeyer, A. Jenke (2005)
Peginterferon alfa‐2b plus ribavirin treatment in children and adolescents with chronic hepatitis CHepatology, 41
Levels Nutt, H. Hassan, Judy Lindsey, L. Lamps, J. Raufman (2000)
Liver biopsy in the evaluation of patients with chronic hepatitis C who have repeatedly normal or near-normal serum alanine aminotransferase levels.The American journal of medicine, 109 1
P. Jara, L. Hierro, A. Vega, Carmen Díaz, C. Camarena, E. Frauca, G. Muñoz-bartolo, R. Díez-Dorado, C. Guevara, J. Larrauri, M. Rueda (2008)
Efficacy and Safety of Peginterferon-&agr;2b and Ribavirin Combination Therapy in Children With Chronic Hepatitis C InfectionThe Pediatric Infectious Disease Journal, 27
M. Bonacini, H. Lin, F. Hollinger (2001)
Effect of Coexisting HIV‐1 Infection on the Diagnosis and Evaluation of Hepatitis C VirusJAIDS Journal of Acquired Immune Deficiency Syndromes, 26
Roger Williams (2006)
Global challenges in liver diseaseHepatology, 44
S. Kleinman, H. Alter, M. Busch, P. Holland, G. Tegtmeier, M. Nelles, S. Lee, E. Page, J. Wilber, A. Polito (1992)
Increased detection of hepatitis C virus (HCV)‐infected blood donors by a multiple‐antigen HCV enzyme immunoassayTransfusion, 32
T. Fujisawa, A. Inui, T. Ohkawa, H. Komatsu, Yoshihiro Miyakawa, M. Onoue (1995)
Response to interferon therapy in children with chronic hepatitis C.The Journal of pediatrics, 127 4
I. Jacobson, Robert Brown, J. McCone, M. Black, C. Albert, M. Dragutsky, F. Siddiqui, T. Hargrave, P. Kwo, L. Lambiase, G. Galler, V. Araya, B. Freilich, J. Harvey, L. Griffel, C. Brass (2007)
Impact of weight‐based ribavirin with peginterferon alfa‐2b in african americans with hepatitis C virus genotype 1Hepatology, 46
Cotler, Wartelle, Larson, Gretch, Jensen, Carithers Jr (2000)
Pretreatment symptoms and dosing regimen predict side‐effects of interferon therapy for hepatitis CJournal of Viral Hepatitis, 7
J. Tokars, M. Alter, M. Favero, L. Moyer, L. Bland (1993)
National surveillance of dialysis associated diseases in the United States, 1991.ASAIO journal, 39 4
J. Stockman (2007)
Peginterferon Alfa-2b and Ribavirin for 12 vs 24 weeks in HCV Genotype 2 or 3Yearbook of Pediatrics, 2007
Ohto Ohto, Terazawa Terazawa, Sasaki Sasaki, Sasaki Sasaki, Hino Hino, Ishiwata Ishiwata (1994)
Transmission of hepatitis C virus from mothers to infantsN Engl J Med, 330
L. Rostaing, J. Izopet, E. Baron, M. Duffaut, J. Puel, D. Durand (1995)
Treatment of chronic hepatitis C with recombinant interferon alpha in kidney transplant recipients.Transplantation, 59 10
E. Bini, S. Mehandru (2006)
Sustained virological response rates and health‐related quality of life after interferon and ribavirin therapy in patients with chronic hepatitis C virus infection and persistently normal alanine aminotransferase levelsAlimentary Pharmacology & Therapeutics, 23
G. Schreiber, M. Busch, S. Kleinman, J. Korelitz (1996)
The Risk of Transfusion-Transmitted Viral InfectionsThe New England Journal of Medicine, 334
W. Kim (2002)
The burden of hepatitis C in the United StatesHepatology, 36
D. Sylvestre, A. Litwin, Barry Clements, M. Gourevitch (2005)
The impact of barriers to hepatitis C virus treatment in recovering heroin users maintained on methadone.Journal of substance abuse treatment, 29 3
Radloff Radloff (1977)
The CES?D Scale: a self?report depression scale for research in the general populationJ Applied Psychol Measurement, 1
A. Beck, C. Ward, M. Mendelson, J. Mock, J. Erbaugh (1961)
An inventory for measuring depression.Archives of general psychiatry, 4
S. Stramer, S. Caglioti, D. Strong (2000)
NAT of the United States and Canadian blood supplyTransfusion, 40
J. Barrio, M. García-Bengoechea, J. Emparanza, J. Arenas (1998)
[The prevalence of hepatitis C virus infection].Gastroenterologia y hepatologia, 21 5
Hopi Lin, J. Kao, H. Hsu, Y. Ni, Mei‐Hwei Chang, Su‐cheng Huang, L. Hwang, Pei‐Jer Chen, Ding‐Shinn Chen (1995)
Absence of infection in breast-fed infants born to hepatitis C virus-infected mothers.The Journal of pediatrics, 126 4
M. Schaefer, Axel Hinzpeter, Ariane Mohmand, G. Janssen, M. Pich, M. Schwaiger, R. Sarkar, A. Friebe, A. Heinz, Michael Kluschke, Marlene Ziemer, Juri Gutsche, V. Weich, J. Halangk, T. Berg (2007)
Hepatitis C treatment in “difficult‐to‐treat” psychiatric patients with pegylated interferon‐alpha and ribavirin: Response and psychiatric side effectsHepatology, 46
A. Bruchfeld, K. Lindahl, O. Reichard, T. Carlsson, R. Schvarcz (2006)
Pegylated interferon and ribavirin treatment for hepatitis C in haemodialysis patientsJournal of Viral Hepatitis, 13
M. Guido, M. Rugge, P. Jara, L. Hierro, R. Giacchino, J. Larrauri, L. Zancan, G. Leandro, C. Marino, F. Balli, A. Bagni, A. Timitilli, F. Bortolotti (1998)
Chronic hepatitis C in children: the pathological and clinical spectrum.Gastroenterology, 115 6
Thomas Kramer, Gregory Gaar, C. Ray, Linda Minnich, Jack Copeland, James Connor (1990)
Hemodialysis clearance of intravenously administered ribavirinAntimicrobial Agents and Chemotherapy, 34
D. Kleiner (2005)
The liver biopsy in chronic hepatitis C: a view from the other side of the microscope.Seminars in liver disease, 25 1
M. Shiffman, A. Mihas, F. Millwala, R. Sterling, V. Luketic, R. Stravitz, A. Sanyal (2007)
Treatment of Chronic Hepatitis C Virus in African Americans With Genotypes 2 and 3The American Journal of Gastroenterology, 102
J. Lam, F. Mcomish, S. Burns, P. Yap, J. Mok, P. Simmonds (1993)
Infrequent vertical transmission of hepatitis C virus.The Journal of infectious diseases, 167 3
G. Fattovich, G. Giustina, F. Degos, F. Tremolada, G. Diodati, P. Almasio, F. Nevens, A. Solinas, D. Mura, J. Brouwer, H. Thomas, C. Njapoum, C. Casarin, P. Bonetti, P. Fuschi, J. Basho, A. Tocco, A. Bhalla, R. Galassini, F. Noventa, S. Schalm, G. Realdi (1997)
Morbidity and mortality in compensated cirrhosis type C: a retrospective follow-up study of 384 patients.Gastroenterology, 112 2
R. Jhaveri, William Grant, T. Kauf, J. McHutchison (2006)
The burden of hepatitis C virus infection in children: estimated direct medical costs over a 10-year period.The Journal of pediatrics, 148 3
Maria Cid, Jos� Hern�ndez-Rodr�guez, Jordi Robert, Ana R�o, Jordi Casademont, Blanca Coll-Vinent, Josep Grau, H. Kleinman, Alvaro Urbano-M�rquez, Francesc Cardellach (1999)
Interferon-alpha may exacerbate cryoblobulinemia-related ischemic manifestations: an adverse effect potentially related to its anti-angiogenic activity.Arthritis and rheumatism, 42 5
S. Brillanti, M. Foli, S. Gaiani, C. Masci, M. Miglioli, Luigi Barbara (1993)
Persistent hepatitis C viraemia without liver diseaseThe Lancet, 341
Sawako Kobayashi, T. Takeda, M. Enomoto, A. Tamori, N. Kawada, D. Habu, H. Sakaguchi, T. Kuroda, K. Kioka, S. Kim, T. Kanno, T. Ueda, M. Hirano, S. Fujimoto, H. Jomura, S. Nishiguchi, S. Seki (2007)
Development of hepatocellular carcinoma in patients with chronic hepatitis C who had a sustained virological response to interferon therapy: a multicenter, retrospective cohort study of 1124 patientsLiver International, 27
Thomas Thomas, Seeff Seeff (2005)
Natural history of hepatitis CClin Liver Dis, 9
Soriano Soriano, Bravo Bravo, Garcia‐Samaniego Garcia‐Samaniego, Castilla Castilla, Gonzalez Gonzalez, Castro Castro (1997)
Relapses of chronic hepatitis C in HIV?infected patients who responded to interferon therapyAids, 11
H. Lane, V. Davey, J. Kovacs, J. Feinberg, J. Metcalf, B. Herpin, R. Walker, L. Deyton, R. Davey, J. Falloon (1990)
Interferon-alpha in patients with asymptomatic human immunodeficiency virus (HIV) infection. A randomized, placebo-controlled trial.Annals of internal medicine, 112 11
K. Sherman, S. Rouster, R. Chung, N. Rajicic (2002)
Hepatitis C Virus prevalence among patients infected with Human Immunodeficiency Virus: a cross-sectional analysis of the US adult AIDS Clinical Trials Group.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 34 6
M. Rendina, A. Schena, N. Castellaneta, F. Losito, A. Amoruso, G. Stallone, F. Schena, A. Leo, A. Francavilla (2007)
The treatment of chronic hepatitis C with peginterferon alfa-2a (40 kDa) plus ribavirin in haemodialysed patients awaiting renal transplant.Journal of hepatology, 46 5
F. Fabrizi, G. Dulai, V. Dixit, S. Bunnapradist, Paul Martin, Paul Martin (2003)
Meta‐analysis: interferon for the treatment of chronic hepatitis C in dialysis patientsAlimentary Pharmacology & Therapeutics, 18
Sean Carroll, R. Riffenburgh, T. Roberts, Elizabeth Myhre (2002)
Tattoos and body piercings as indicators of adolescent risk-taking behaviors.Pediatrics, 109 6
Jadoul Jadoul, Cornu Cornu, van Ypersele van Ypersele, Strihou Strihou (1998)
Universal precautions prevent hepatitis C virus transmission: a 54 month follow?up of the Belgian Multicenter StudyKidney Int, 53
Richard Moore (1999)
Human immunodeficiency virus infection, anemia, and survival.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 29 1
M. Buti, F. Sánchez-Ávila, Y. Lurie, C. Stalgis, A. Valdés, M. Martell, R. Esteban (2002)
Viral kinetics in genotype 1 chronic hepatitis C patients during therapy with 2 different doses of peginterferon alfa‐2b plus ribavirinHepatology, 35
Ming‐Lung Yu, C. Dai, Jee‐Fu Huang, Nai‐Jen Hou, Li‐Po Lee, M. Hsieh, Chang-Fu Chiu, Zu-Yau Lin, Shinn-Cherng Chen, M. Hsieh, L. Wang, W. Chang, W. Chuang (2006)
A randomised study of peginterferon and ribavirin for 16 versus 24 weeks in patients with genotype 2 chronic hepatitis CGut, 56
D. Rockey, D. Bissell (2006)
Noninvasive measures of liver fibrosisHepatology, 43
S. Mauss, W. Valenti, J. Depamphilis, F. Duff, L. Cupelli, S. Passe, J. Solsky, F. Torriani, D. Dieterich, D. Larrey (2004)
Risk factors for hepatic decompensation in patients with HIV/HCV coinfection and liver cirrhosis during interferon-based therapyAIDS, 18
I. Jacobson, F. Ahmed, M. Russo, E. Lebovics, D. Dieterich, S. Esposito, N. Bach, F. Klion, H. Tobias, L. Antignano, Robert Brown, David Gabbaizadeh, J. Geders, H. Levendoglu (2004)
Interferon Alpha-2b and Ribavirin for Patients with Chronic Hepatitis C and Normal ALTThe American Journal of Gastroenterology, 99
S. Polywka, L. Pembrey, P. Tovo, M. Newell (2006)
Accuracy of HCV‐RNA PCR tests for diagnosis or exclusion of vertically acquired HCV infectionJournal of Medical Virology, 78
F. Pessione, F. Degos, P. Marcellin, V. Duchatelle, C. Njapoum, M. Martinot-Peignoux, C. Degott, D. Valla, S. Erlinger, B. Rueff (1998)
Effect of alcohol consumption on serum hepatitis C virus RNA and histological lesions in chronic hepatitis CHepatology, 27
A. Levey, J. Coresh, E. Balk, A. Kausz, A. Levin, M. Steffes, R. Hogg, R. Perrone, J. Lau, G. Eknoyan (2003)
National Kidney Foundation Practice Guidelines for Chronic Kidney Disease: Evaluation, Classification, and StratificationAnnals of Internal Medicine, 139
R. Mccollum (1969)
The natural history of hepatitis.Bulletin of the New York Academy of Medicine, 45 2
J. Cadranel, P. Rufat, F. Degos (2000)
Practices of Liver Biopsy in France: Results of a Prospective Nationwide SurveyHepatology, 32
J. Floege (2003)
Recurrent glomerulonephritis following renal transplantation: an update.Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 18 7
A. Sánchez‐Fueyo, J. Restrepo, L. Quintó, M. Bruguera, L. Grande, J. Sánchez‐Tapias, J. Rodés, A. Rimola (2002)
Impact of the recurrence of hepatitis C virus infection after liver transplantation on the long-term viability of the graft.Transplantation, 73 1
Seth Crockett, T. Kaltenbach, E. Keeffe (2006)
Do we still need a liver biopsy? Are the serum fibrosis tests ready for prime time?Clinics in liver disease, 10 3
Ranjana Sharma, S. Bansal, A. Gupta, S. Gulati, Anant Kumar, N. Prasad (2006)
Chronic hepatitis C virus infection in renal transplant: treatment and outcomeClinical Transplantation, 20
N. Singh, T. Gayowski, C. Wannstedt, A. Shakil, M. Wagener, J. Fung, I. Marino (1998)
Interferon-alpha for prophylaxis of recurrent viral hepatitis C in liver transplant recipients: a prospective, randomized, controlled trial.Transplantation, 65 1
K. Hobbs, G. Dusheiko (1992)
Management of hepatocellular carcinoma.Journal of hepatology, 15 3
D. Jorgensen, B. Andersen (1974)
[Patient information].Sygeplejersken, 74 18
S. Mukherjee (2005)
Pegylated interferon alfa-2a and ribavirin for recurrent hepatitis C after liver transplantation.Transplantation proceedings, 37 10
(1995)
American Gastroenterological Association policy statement on the use of medical practice guidelines by managed care organizations and insurance carriers.Gastroenterology, 108 3
A. Bruchfeld, H. Wilczek, C. Elinder (2004)
Hepatitis C Infection, Time in Renal-Replacement Therapy, and Outcome after Kidney TransplantationTransplantation, 78
Samir Gupta, A. Pittenger, S. Swan, T. Marbury, E. Tobillo, V. Batra, M. Sack, P. Glue, S. Jacobs, M. Affrime (2002)
Single‐Dose Pharmacokinetics and Safety of Pegylated Interferon‐α2b in Patients with Chronic Renal DysfunctionThe Journal of Clinical Pharmacology, 42
Goedert Goedert, Chen Chen, Preiss Preiss, Aledort Aledort, Rosenberg Rosenberg (2007)
Reconstruction of the hepatitis C virus epidemic in the US hemophilia population, 1940?1990Am J Epidemiol, 165
D. Salmon-Céron, L. Chauvelot‐Moachon, S. Abad, B. Silbermann, P. Sogni (2001)
Mitochondrial toxic effects and ribavirinThe Lancet, 357
G. Calleri, G. Cariti, F. Gaiottino, F. Rosa, O. Bargiacchi, S. Audagnotto, S. Quaglia, T. Blasi, P. Romano, A. Traverso, G. Leo, R. Carbone, B. Mastro, M. Tinelli, P. Caramello, G. Perri (2007)
A short course of pegylated interferon‐α in acute HCV hepatitisJournal of Viral Hepatitis, 14
J. Olynyk, K. Reddy, A. Bisceglie, L. Jeffers, T. Parker, Jason Radick, E. Schiff, B. Bacon (1995)
Hepatic iron concentration as a predictor of response to interferon alfa therapy in chronic hepatitis C.Gastroenterology, 108 4
Harmit Kalia, P. Lopez, Paul Martin (2007)
Treatment of HCV in patients with renal failure.Archives of medical research, 38 6
P. Glue (1999)
The clinical pharmacology of ribavirin.Seminars in liver disease, 19 Suppl 1
Kidney Int Suppl
U. Neumann, T. Berg, M. Bahra, G. Puhl, O. Guckelberger, J. Langrehr, P. Neuhaus (2004)
Long-term outcome of liver transplants for chronic hepatitis C: a 10-year follow-upTransplantation, 77
Z. Goodman, H. Makhlouf, Lea Liu, W. Balistreri, R. Gonzalez-Peralta, B. Haber, M. Jonas, P. Mohan, J. Molleston, K. Murray, M. Narkewicz, P. Rosenthal, Lesley Smith, Patricia Robuck, K. Schwarz (2008)
Pathology of chronic hepatitis C in children: Liver biopsy findings in the Peds‐C TrialHepatology, 47
S. El-Kamary, J. Serwint, A. Joffe, M. Santosham, A. Duggan (2003)
Prevalence of hepatitis C virus infection in urban children.The Journal of pediatrics, 143 1
B. Pearlman, C. Ehleben, S. Saifee (2007)
Treatment extension to 72 weeks of peginterferon and ribavirin in hepatitis c genotype 1–infected slow respondersHepatology, 46
G. Everson, J. Trotter, L. Forman, M. Kugelmas, Arthur Halprin, B. Fey, C. Ray (2005)
Treatment of advanced hepatitis C with a low accelerating dosage regimen of antiviral therapyHepatology, 42
P. Glue, J. Fang, R. Rouzier-Panis, C. Raffanel, R. Sabo, Samir Gupta, M. Salfi, S. Jacobs (2000)
Pegylated interferon‐α2b: Pharmacokinetics, pharmacodynamics, safety, and preliminary efficacy dataClinical Pharmacology & Therapeutics, 68
A. Alberti, L. Benvegnu' (2003)
Management of hepatitis C.Journal of hepatology, 38 Suppl 1
M. Backmund, K. Meyer, M. Zielonka, D. Eichenlaub (2001)
Treatment of hepatitis C infection in injection drug usersHepatology, 34
Jian-Wu Yu, gui-qiang Wang, Li-jie Sun, Xiao-guang Li, Shu-chen Li (2007)
Predictive value of rapid virological response and early virological response on sustained virological response in HCV patients treated with pegylated interferon α‐2a and ribavirinJournal of Gastroenterology and Hepatology, 22
R. D'Souza, M. Glynn, I. Ushiro-Lumb, R. Feakins, P. Domizio, L. Mears, Elspeath Alsced, P. Kumar, C. Sabin, G. Foster (2005)
Prevalence of hepatitis C-related cirrhosis in elderly Asian patients infected in childhood.Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association, 3 9
C. Meyers, L. Seeff, C. Stehman-Breen, J. Hoofnagle (2003)
Hepatitis C and renal disease: an update.American journal of kidney diseases : the official journal of the National Kidney Foundation, 42 4
W. Vogel, I. Graziadei, F. Umlauft, C. Datz, F. Hackl, S. Allinger, K. Grünewald, J. Patsch (1996)
High-dose interferon-α2b treatment prevents chronicity in acute hepatitis CDigestive Diseases and Sciences, 41
U. Neumann, T. Berg, M. Bahra, D. Seehofer, J. Langrehr, R. Neuhaus, C. Radke, P. Neuhaus (2004)
Fibrosis progression after liver transplantation in patients with recurrent hepatitis C.Journal of hepatology, 41 5
A. Bruchfeld, K. Lindahl, L. Ståhle, M. Söderberg, R. Schvarcz (2003)
Interferon and ribavirin treatment in patients with hepatitis C-associated renal disease and renal insufficiency.Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 18 8
H. Fontaine, A. Vallet-Pichard, Claudia Equi-Andrade, B. Nalpas, V. Verkarre, M. Chaix, P. Lebray, R. Sobesky, J. Serpaggi, H. Kreis, S. Pol (2004)
Histopathologic Efficacy of Ribavirin Monotherapy in Kidney Allograft Recipients with Chronic Hepatitis CTransplantation, 78
P. Cacoub, D. Saadoun, N. Limal, D. Sène, O. Lidove, J. Piette (2005)
PEGylated interferon alfa-2b and ribavirin treatment in patients with hepatitis C virus-related systemic vasculitis.Arthritis and rheumatism, 52 3
M. Manns, J. McHutchison, S. Gordon, V. Rustgi, M. Shiffman, R. Reindollar, Z. Goodman, K. Koury, M. Ling, J. Albrecht (2001)
Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trialThe Lancet, 358
M. Bahra, U. Neumann, D. Jacob, T. Berg, R. Neuhaus, J. Langrehr, P. Neuhaus (2007)
Outcome after liver re‐transplantation in patients with recurrent chronic hepatitis CTransplant International, 20
M. Yano, H. Kumada, M. Kage, K. Ikeda, K. Shimamatsu, O. Inoue, E. Hashimoto, Jay, H., Lefkowitch, J. Ludwig, Kunio Okuda (1996)
The long‐term pathological evolution of chronic hepatitis CHepatology, 23
V. Puro, N. Petrosillo, G. Ippolito (1995)
Risk of hepatitis C seroconversion after occupational exposures in health care workers. Italian Study Group on Occupational Risk of HIV and Other Bloodborne Infections.American journal of infection control, 23 5
M. Romero‐Gomez, L. Grande, M. Nogales, M. Fernández, M. Chávez, M. Castro (2001)
Intrahepatic hepatitis C virus replication is increased in patients with regular alcohol consumption.Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver, 33 8
S. Villano, D. Vlahov, K. Nelson, S. Cohn, David Thomas (1999)
Persistence of viremia and the importance of long‐term follow‐up after acute hepatitis C infectionHepatology, 29
D. Marelli, J. Bresson, H. Laks, B. Kubak, G. Fonarow, F. Tsai, Julie Tran, S. Weston (2002)
Hepatitis C‐positive Donors in Heart TransplantationAmerican Journal of Transplantation, 2
F. Stickel, E. Patsenker, D. Schuppan (2005)
Herbal hepatotoxicity.Journal of hepatology, 43 5
Ze-Zhou Song (2008)
Acute viral hepatitis increases liver stiffness values measured by transient elastographyHepatology, 48
Pratima Sharma, J. Marrero, R. Fontana, J. Greenson, H. Conjeevaram, G. Su, F. Askari, Patricia Sullivan, A. Lok (2007)
Sustained virologic response to therapy of recurrent hepatitis C after liver transplantation is related to early virologic response and dose adherenceLiver Transplantation, 13
P. Marcellin, T. Asselah, N. Boyer (2002)
Fibrosis and disease progression in hepatitis CHepatology, 36
M. Wiese, F. Berr, M. Lafrenz, H. Porst, U. Oesen (2000)
Low frequency of cirrhosis in a hepatitis C (genotype 1b) single‐source outbreak in germany: A 20‐year multicenter studyHepatology, 32
Laure Valério, Y. Yazdanpanah, I. Poizot-Martin, É. Rosenthal, C. Marimoutou, J. Gastaut, A. Tran, P. Dellamonica, K. Freedberg, C. Pradier (2008)
Baseline CD4 Cell Count and Outcome of Pegylated Interferon Plus Ribavirin Therapy in HIV/Hepatitis C Virus-Coinfected PatientsJAIDS Journal of Acquired Immune Deficiency Syndromes, 47
A. Cox, D. Netski, T. Mosbruger, S. Sherman, S. Strathdee, D. Ompad, D. Vlahov, D. Chien, V. Shyamala, S. Ray, David Thomas (2005)
Prospective evaluation of community-acquired acute-phase hepatitis C virus infection.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 40 7
P. Maisonneuve, L. Agodoa, R. Gellert, J. Stewart, G. Buccianti, A. Lowenfels, R. Wolf, E. Jones, Alex Dsiney, D. Briggs, M. Mccredie, P. Boyle (1999)
Cancer in patients on dialysis for end-stage renal disease: an international collaborative studyThe Lancet, 354
V. Ortiz, M. Berenguer, J. Rayón, D. Carrasco, J. Berenguer (2002)
Contribution of obesity to hepatitis C-related fibrosis progressionAmerican Journal of Gastroenterology, 97
T. Berg, M. Wagner, S. Nasser, C. Sarrazin, T. Heintges, T. Gerlach, P. Buggisch, T. Goeser, J. Rasenack, G. Pape, W. Schmidt, B. Kallinowski, H. Klinker, U. Spengler, P. Martus, U. Alshuth, S. Zeuzem (2006)
Extended treatment duration for hepatitis C virus type 1: comparing 48 versus 72 weeks of peginterferon-alfa-2a plus ribavirin.Gastroenterology, 130 4
J. Hoofnagle (2002)
Course and outcome of hepatitis CHepatology, 36
Bo Choy, T. Chan, K. Lai (2006)
Recurrent Glomerulonephritis After Kidney TransplantationAmerican Journal of Transplantation, 6
K. Doucette, J. Weinkauf, S. Sumner, K. Ens, D. Lien (2007)
Treatment of hepatitis C in potential lung transplant candidates.Transplantation, 83 12
Chung Chung, Andersen Andersen, Volberding Volberding, Robbins Robbins, Liu Liu, Sherman Sherman (2004)
Peginterferon Alfa?2a plus ribavirin versus interferon alfa?2a plus ribavirin for chronic hepatitis C in HIV?coinfected personsN Engl J Med, 351
V. Soriano, J. García-Samaniego, R. Bravo, J. González, Á. Castro, J. Castilla, P. Martínez-Odriozola, M. Colmenero, E. Carballo, D. Suárez, F. Rodríguez-Piñero, A. Moreno, J. Romero, J. Pedreira, J. González-Lahoz (1996)
Interferon α for the Treatment of Chronic Hepatitis C in Patients Infected with Human Immunodeficiency VirusClinical Infectious Diseases, 23
Nevin Yılmaz, M. Shiffman, R. Stravitz, R. Sterling, V. Luketic, A. Sanyal, A. Mills, M. Contos, Adrian Coterell, D. Maluf, M. Posner, R. Fisher (2007)
A prospective evaluation of fibrosis progression in patients with recurrent hepatitis C virus following liver transplantationLiver Transplantation, 13
E. Golub, M. Latka, H. Hagan, J. Havens, S. Hudson, F. Kapadia, Jennifer Campbell, R. Garfein, David Thomas, S. Strathdee (2004)
Screening for depressive symptoms among HCV-infected injection drug users: Examination of the utility of the CES-D and the beck depression inventoryJournal of Urban Health, 81
V. Desmet, M. Gerber, J. Hoofnagle, M. Manns, P. Scheuer (1994)
Classification of chronic hepatitis: Diagnosis, grading and stagingHepatology, 19
C. Raison, M. Demetrashvili, L. Capuron, Andrew Miller (2005)
Neuropsychiatric adverse effects of interferon-alpha: recognition and management.CNS drugs, 19 2
F. Lunel, J. Cadranel, Michel Rosenheim, Richard Dorent, Vincent Di–Martino, Christopher Payan, Catherine Fretz, J. Ghoussoub, Brigitte Bernard, Bruno Dumont, Michèle Perrin, Iranj Gandjbachkh, J. Huraux, Lieven Stuyver, Pierre Opolon (2000)
Hepatitis virus infections in heart transplant recipients: epidemiology, natural history, characteristics, and impact on survival.Gastroenterology, 119 4
J. Gerlach, H. Diepolder, R. Zachoval, N. Gruener, M. Jung, A. Ulsenheimer, W. Schraut, C. Schirren, M. Waechtler, M. Backmund, G. Pape (2003)
Acute hepatitis C: high rate of both spontaneous and treatment-induced viral clearance.Gastroenterology, 125 1
K. Workowski, Stuart Berman (2006)
Sexually transmitted diseases treatment guidelines, 2006.MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports, 55 RR-11
R. Wejstål, A. Widell, A. Månsson, S. Hermodsson, G. Norkrans (1992)
Mother-to-Infant Transmission of Hepatitis C VirusAnnals of Internal Medicine, 117
M. Vogt, T. Lang, G. Frösner, C. Klingler, A. Sendl, A. Zeller, B. Wiebecke, B. Langer, H. Meisner, J. Hess (1999)
Prevalence and clinical outcome of hepatitis C infection in children who underwent cardiac surgery before the implementation of blood-donor screening.Clinical pediatrics, 39 4
P. Tovo, H. Souayah, D. Grossman, J. Lévy (2001)
Effects of mode of delivery and infant feeding on the risk of mother-to-child transmission of hepatitis C virus. European Paediatric Hepatitis C Virus Network.BJOG : an international journal of obstetrics and gynaecology, 108 4
N. Afdhal, D. Dieterich, P. Pockros, E. Schiff, M. Shiffman, M. Sulkowski, T. Wright, Z. Younossi, B. Goon, K. Tang, P. Bowers (2004)
Epoetin alfa maintains ribavirin dose in HCV-infected patients: a prospective, double-blind, randomized controlled study.Gastroenterology, 126 5
S. Zeuzem, M. Diago, E. Gane, K. Reddy, P. Pockros, D. Prati, M. Shiffman, P. Farci, N. Gitlin, C. O’Brien, F. Lamour, P. Lardelli (2004)
Peginterferon alfa-2a (40 kilodaltons) and ribavirin in patients with chronic hepatitis C and normal aminotransferase levels.Gastroenterology, 127 6
Takayuki Suzuki, K. Yonemura, T. Miyaji, Hiroyuki Suzuki, R. Takahira, Y. Fujigaki, T. Fujimoto, Akira Hishida (2001)
Progressive renal failure and blindness due to retinal hemorrhage after interferon therapy for hepatitis C virus-associated membranoproliferative glomerulonephritis.Internal medicine, 40 8
M. Wiese, K. Grüngreiff, W. Güthoff, M. Lafrenz, U. Oesen, H. Porst (2005)
Outcome in a hepatitis C (genotype 1b) single source outbreak in Germany--a 25-year multicenter study.Journal of hepatology, 43 4
J. Pawlotsky (2002)
Molecular diagnosis of viral hepatitis.Gastroenterology, 122 6
V. Soriano, R. Bravo, J. García-Samaniego, J. Castilla, J. González, Á. Castro, J. Llibre (1997)
Relapses of chronic hepatitis C in HIV-infected patients who responded to interferon therapy. Hepatitis/HIV Spanish Study Group.AIDS, 11 3
M. Shiffman, A. Bisceglie, K. Lindsay, C. Morishima, E. Wright, G. Everson, A. Lok, T. Morgan, H. Bonkovsky, William Lee, J. Dienstag, M. Ghany, Z. Goodman, J. Everhart (2004)
Peginterferon alfa-2a and ribavirin in patients with chronic hepatitis C who have failed prior treatment.Gastroenterology, 126 4
B. Edlin, K. Seal, J. Lorvick, A. Kral, D. Ciccarone, Lisa Moore, Bernard Lo (2001)
Is it justifiable to withhold treatment for hepatitis C from illicit-drug users?The New England journal of medicine, 345 3
C. Puoti, R. Castellacci, F. Montagnese (2000)
Hepatitis C virus carriers with persistently normal aminotransferase levels: healthy people or true patients?Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver, 32 7
P. Cresta, L. Musset, P. Cacoub, L. Frangeul, D. Vitour, T. Poynard, P. Opolon, D. Nguyen, F. Golliot, J. Piette, J. Huraux, F. Lunel (1999)
Response to interferon α treatment and disappearance of cryoglobulinaemia in patients infected by hepatitis C virusGut, 45
L. Seeff (2002)
Natural history of chronic hepatitis CHepatology, 36
T. Liang, B. Rehermann, L. Seeff, J. Hoofnagle (2000)
Pathogenesis, Natural History, Treatment, and Prevention of Hepatitis CAnnals of Internal Medicine, 132
F. Locatelli, A. Nissenson, B. Barrett, R. Walker, D. Wheeler, K. Eckardt, N. Lameire, G. Eknoyan (2008)
Clinical practice guidelines for anemia in chronic kidney disease: problems and solutions. A position statement from Kidney Disease: Improving Global Outcomes (KDIGO).Kidney international, 74 10
This document has been approved by the AASLD, the Infectious Diseases Society of America, and the American College of Gastroenterology. Preamble These recommendations provide a data‐supported approach to establishing guidelines. They are based on the following: (1) a formal review and analysis of the recently published world literature on the topic (Medline search up to September 2008); (2) the American College of Physicians' Manual for Assessing Health Practices and Designing Practice Guidelines ; 1 (3) guideline policies, including the American Association for the Study of Liver Diseases' (AASLD) Policy on the Development and Use of Practice Guidelines and the American Gastroenterological Association's Policy Statement on the Use of Medical Practice Guidelines; 2 and (4) the experience of the authors in regard to hepatitis C. Intended for use by physicians, these recommendations suggest preferred approaches to the diagnostic, therapeutic and preventive aspects of care. They are intended to be flexible, in contrast to standards of care, which are inflexible policies to be followed in every case. Specific recommendations are based on relevant published information. To more fully characterize the quality of evidence supporting recommendations, the Practice Guidelines Committee of the AASLD requires a Class (reflecting benefit versus risk) and
Hepatology – Wiley
Published: Apr 1, 2009
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.